TW460446B - Thiol compounds - Google Patents
Thiol compounds Download PDFInfo
- Publication number
- TW460446B TW460446B TW84113172A TW84113172A TW460446B TW 460446 B TW460446 B TW 460446B TW 84113172 A TW84113172 A TW 84113172A TW 84113172 A TW84113172 A TW 84113172A TW 460446 B TW460446 B TW 460446B
- Authority
- TW
- Taiwan
- Prior art keywords
- acid
- compound
- formula
- solution
- reaction
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
4 6 0 4 4 6 _ 充 se. 3. A7 B7 五、發明説明(/ ) 為合及 作化 , 開B)物 有ne合 俗pe化 ,baB 之ar硫 言U類 而 新 詳念之 .且e物 ,S間 物碩中 合 的 化之丨 醇 _ 硫施 關服 有口 偽可 明類 發種 本些 某 物 性 活 菌 抗 強 示 顯 其 鹽 成 加两 酸有 之 , 物者 合再 化 * 醇法 硫方 該之 。 關物物 有合間 使 化 等 該合 備穎 製新 翮之 有中 步法 1 製 進該 且於 用 經濟部中央標準局員工消費合作杜印製 (請先閱讀背面之注意事項再填寫本頁) 中 化抗部藥遘議者 和 成 之異大施可服患 圍 射望 注期 由上 經務 僅實 上床 床臨 臨在 議 , 建的 被目 之 物境 合環 或 鍵優止 主有為 林具前 西議目 尼建到 盤被, 基已率 羧典一收 的 一 吸 諝有低 所,的 有中們 具物·它 多合為 許化因 現等 , 發該而 已從然 , 且 α 今 ,性 迄物活 合菌 配者 患 於 的監 份 於 一 擇 化 念 療 台 □ 於 -可 較亦 fcfc其 射因 注及 與。 。藥 徑施 。 路地用 置便有 劑方常 種且非 數易上 之容床 藥其臨 施因在 物且而 藥佳藥 恃施 為中 物家 範 菌 抗 之 〇 圍物 範合 泛化 廣念 具配 展碩 發之 要藥 箱施 烈服 強口 此可 因且 ,性 地活 帶菌 附抗 強 下 境 環之 述藥 上施碩卜 於服 之 C 口 為示物 配 碩 發 本念 明 合 b /1 可作 關(f 有有 究具 研等 地該 再現 i 發 經且 人 , 明 發物 之 § 念 啉 唑 if 表合 X)化 ί的 基 硫 基 基3- 代- 取 之 上 置 位 2-基 之2-鏈 主 烷 丁 環 雜 氮4 6 0 4 4 6 _ charge se. 3. A7 B7 V. Description of the invention (/) For combination and modification, open B) The material has ne custom pe, baB ar sulfur U class and new details read . And the e-, S-intermediate chemical combination of alcohol _ sulphur application has oral pseudo-clarifiable hair this kind of some physical properties of live bacteria show strong resistance to its salt to add two acids, the person who Combining and Refining * This should be done with alcohol sulfur. Customs and materials are combined and used to make the new system. There is a mid-step method1. This system is printed by the consumer cooperation of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling this page). ) Sinochem's anti-drug drug critics and Cheng Zhida can take the perimeter shots and watch the period of attention. The Shangjingwu only goes to the bed to face the discussion. It was built for the quilt before the forestry, and it has a low intake, and it has some characteristics. It is a combination of Xu Hua and Xu Hua. It should be taken for granted. And, at present, the supervised part of the sex-synaptic viable spouse partner is in a selective therapy station □ In comparison with fcfc, it can be injected and injected. . Drug path application. For road and floor use, there are regular and non-easy container medicines that are applied on the ground, and the best medicines are applied to the Chinese medicine family fungus resistance. Zhan Shuofa's essential medicine box, Shi Liefu, has a strong mouth. This can be caused by the fact that the live drug is attached to the drug that is resistant to the strong environment. / 1 can be related (f should be reproduced, etc. i should be reproduced i hair meridian and human, Mingfa's § quinolinazole if expressing X) of the thiol 3-generation-take the top 2-chain main alkanecycloaza
本紙張尺度適用中國國家標牟(CNS > Μ規格(210X297公釐) 式 下 以 4 6 0 4 4 6 C ,"—- f ;.〆.·* 匕· : - : > A7 ;ik ft, 86. 3. 2 〇 B7 五、發明説明(> )' 或典型地如以下式(IX)表示之碩配念化合物The size of this paper is applicable to the Chinese national standard (CNS > M specification (210X297 mm), with a formula of 4 6 0 4 4 6 C, " —- f; .〆. · * Dagger ·:-: >A7; ik ft, 86. 3. 2 〇B7 V. Description of the invention (>) 'or a master compound which is typically represented by the following formula (IX)
化優 酯有 由具 It 物 之生 基衍 殘酯 酯之 定得 待製 有而 ,基 者羧 再的 ,置 性位 活3-S 的 抗物 高合 身化 本逑 示上 顯於 可物 時生 解衍 水酯 速述 迅上 内現 體發 活此 於因 當且 外 -此物 * 合 率化 收X) 吸(I 的式 管上 養成 滋化 從轉 之度 異再 於述 ,上 m 豳 施有 服其 口此 於因 用且 是 , S 式 待形 * 0 劑趨 菌述 抗前 之的 異物 優合 上化 床X) 臨Π 為式 作述 可上 申歟 利 ., 專97 本73 6 B 2 /IV 者8/ 患第 於列 用糸 使請 已申). 物利等 生專等 衍固號 酯美39 其;20 及號6 物96第 合04IS 化17申) - .—, X 6 和 (I第專 式諸洲 1-式 之上 示於 表為 X)其 /1 /V 式基 上硫 以基 將3- 於· 用 供 提 僳 的 目基 要2- 主咐 之 唑 明 f pi 發-ιπ 本3’ 烷 丁 琿 雜 0 配 碩 至 引 地 效 有 \/ 基 代 取 擞 待 的 置 位 I 2 之 物 合 化 (請先閱讀背面之注意事項再填寫本頁) 袈. 經濟部中央標準局員工消費合作社印裝 其供環 之提雜 合 明明氮 化發發*) 含本本-¾ 念 2 物The best esters are based on the residues of the esters derived from the bio-based residues of the It. To be prepared, the bases are carboxyl, and the repositioned 3-S antibodies are highly conformable. A brief description of Shishengjieshuishui ester is quickly activated on the inner body. This is due to the fact that it is outside-this thing * the combined rate of the received X) Suction (I's style on the tube to nourish and change from the degree of change to the above, on m You Shifu has a good idea for this purpose and is, S-type to be shaped * 0 agent before the antibacterial agent is resistant to foreign matter, and you can go to the bed. 73 6 B 2 / IV 8 / If you are suffering from dysentery, please apply for it). Wuli et al., Etc., established the solid ester No. 39 and 20; No. 6 and No. 96, No. 96, 04IS, and 17)-. —, X 6 and (the first formula Zhuzhou 1-type is shown in the table above as X) its / 1 / V formula is based on sulfur-based radicals 3-· with the purpose of the extraction of the basic 2-main Commanded zomine f pi hair-ιπ Ben 3 'Alkane dopant 0 Complementary to ground effect \ / Basic substitution of the material I 2 (Please read the precautions on the back before filling in this Page) 袈. Economy Central Bureau of Standards staff consumer cooperative printing equipment which provide for engagement of the heterocyclic nitrogen of claiming Hair *) containing 2 was read books -¾
基 頸 楚 清 。為 物更 間逑 啉 唑 喀 本紙張尺度適用中國國家榡準(CNS ) A4说格(210X297公釐) * 460446Ί A7 -· JjC. ; ::B7 經濟部中央標芈局員工消費合作.杜印製 五、發明説明( 8〇. 以上式(I)表示之化合物及其酸加成鹽為非常有效的 用以大里有效製備臨床上非常有效的以上式(IX)表示之 碩配念化合物 的關鍵中間物,該(IX)化合物本身 呈現高抗菌活性且當酯化後可以口服施義。 上式(I)化合物之酸加成鹽的實施例包括舆有棟酸像 低鈒脂族酸如乙酸、丙酸、丁酸、三氟乙酸和三氣乙酸 ;經取代或未經取代之苯甲酸如苯甲酸、對-硝基苯甲 酸苯磺酸;(齒)低烷基磺酸如甲磺酸及三氟甲磺酸;經 取代或未經取代之芳族磺酸如苯磺酸、對-硝基苯磺酸、 對-溴苯磺酸、甲苯磺酸和2,4 ,6 -三異丙基苯磺酸;及 有機膝酸如二苯基睇酸;以及與無機酸像氫氣酸、硫酸 、氫溴酸、氫碘酸、痛硼酸、過氣酸和亞硝酸之加成鹽 上述式(I)化合物可藉由任一钽下列三個特擞方法A, B和C製備,例如: 方法蠻化A : 於此方法中,上述式(I)化合物藉由從2 -鹵甲基氮雜 環丙烷作為起始物質以下列反應流程圖(A)所示路徑裂 備: (請先閱讀背面之注意事項再填寫本頁) --° 本紙張尺度速用中國困家標準{ CNS ) A4規格(210X297公釐) 4 6 0 44 6 ^--11 i.· ; A7 B7 五、發明説明(4 )流挥_ (A)The neck is clear. In order to change the size of the paper sheet, the Chinese National Standards Standard (CNS) A4 (210X297 mm) * 460446Ί A7-· JjC.; :: B7 Employee cooperation of the Central Bureau of Standards, Ministry of Economic Affairs. Du Yin Preparation 5. Description of the invention (80. The compound represented by the above formula (I) and its acid addition salt are very effective for the effective preparation of clinically very effective master compound compounds represented by the above formula (IX). Intermediate, the compound (IX) itself exhibits high antibacterial activity and can be administered orally after esterification. Examples of the acid addition salts of the compounds of the above formula (I) include oligoacids such as low fluorene aliphatic acids such as acetic acid , Propionic acid, butyric acid, trifluoroacetic acid, and triacetic acid; substituted or unsubstituted benzoic acid such as benzoic acid, p-nitrobenzoic acid benzenesulfonic acid; (dentate) lower alkyl sulfonic acid such as methanesulfonic acid And trifluoromethanesulfonic acid; substituted or unsubstituted aromatic sulfonic acids such as benzenesulfonic acid, p-nitrobenzenesulfonic acid, p-bromobenzenesulfonic acid, toluenesulfonic acid and 2,4,6-triiso Propylbenzenesulfonic acid; and organic knee acids such as diphenylphosphonic acid; and with inorganic acids like hydrogen acid, sulfuric acid, hydrobromic acid Addition salts of hydroiodic acid, boronic acid, peroxyacid and nitrous acid The compound of formula (I) above can be prepared by any of the following three special methods A, B and C of tantalum, for example: Method A: In this method, the compound of the above formula (I) is prepared by following the path shown in the following reaction scheme (A) by using 2-halomethylazepine as the starting material: (Please read the precautions on the back before (Fill in this page)-° Chinese Standard for Quick Use of Paper Size {CNS) A4 Specification (210X297 mm) 4 6 0 44 6 ^-11 i. ·; A7 B7 V. Description of the Invention (4) _ (A)
本紙張又度適用中國國家標準(CNS ) A4规格(21 Ox 297公釐〉 經濟部中央標準局員工消費合作社印製 4 6 0 4 4 6 A7 B7五、發明説明(了) 於上式中,R表酵基,经取代或未經取代之低级烷基 或芳基;及X表鹵原子。 於本説明害中,術語”低级”意為硪原子之數目逹6傾 或更少,較佳為4或更少。 ”低级烷基”可為直鍵烷基或支繾烷基。其實施例包括 甲基,乙基,正丙基,異丙基,正丁基,異丁基,第二-丁基,第三-丁基,正戊基,異戊基,正己基,異己基, 正庚基及異庚基。其中較佳為甲基,乙基,正丙基,異 丙基,正丁基,異丁基,第二-丁基,第三-丁基。於該 等情形下,該等低级烷基可被苯基取代,該笨基可進一 步被至少一個(較佳為一個或二傾)遘自由羥基,甲氣基 ,乙酷氣基和硝基所组成之取代基取代。 ”醯基”可為從有機羧馥之羧基部分除去羥基之殘留部 份。醛基之實施例包括低级烷匿基如乙睡基,丙豔基和 丁醛基,或經取代或未經取代之苯酵基P ”芳基"可為單琛或多環,且於琛上可進一步具有一催 或以上之取代基如低级烷基,硝基或鹵原子。芳基之實 施例包括苯基,甲苯醯基,二甲苯基,cr-萊基和;S-莱 基。 ”齒原子”包括《,氣,溴和碘原子,及其中較佳為氰 ,漠和碘原子 於下文中,根據各步®詳細地說明以流程圏(A)顯示 之方法: (請先聞讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(21 OX297公釐) 46044 6 A7 B7 經濟部中央標隼局員工消費合作社印製 五、發明説明 ( ) 1 1 步 驟 (a ) 1 i 於 此 步 驟 中 9 使 2- 鹵 甲 基 氮 雜 環 基 琿 丙 院 輿 鏟 反 應 1 1 > 因 此 被 轉 化 成 以 式 (V I I )表示之1 -氮雜雙環 C 1 .1 .0 ] -Μ- J I 丁 院 〇 k, 閱 1 I 讀 1 I 上 述 反 應 進 行 如 下 背 面 1 1 將 之 1 2 · 鹵 甲 基 氮 雜 環 丙 院 溶 解 或 懸 浮 於 反 應 性 愔 性 溶 蘭 中 注 意 1 (該惰性溶劑像選自酵類溶_如甲醇. 乙酵, 丙酵及正 事 項 1 \ 再 1 丁 酵 醚 類 溶 劑 如 二 乙 醚 和 四 氫 呋 喃 1 m 類 溶 劑 如 正 庚 % % ▲ 裝 烷 t 正 己 烷 » 璟 己 院 9 戊 院 和 琛 戊 院 類 溶 如 乙 酸 甲 頁 1 酯 和 乙 酸 乙 酯 : 鹵 類 溶 劑 如 二 氛 甲 院 » 氣 仿 和 四 氮 化 m 1 1 r 或 乙 腈 t 二 甲 基 甲 m 胺 二 甲 基 乙 睡 胺 9 二 甲 基 亞 确 1 I 等 等 較 佳 地 9 m 類 溶 劑 如 二 乙 醚 和 四 氳 呋 喃 ), 及將 1 1 適 合 之 加 至 所 得 溶 液 或 m 浮 液 中 (該篇傜選自有機或 訂 I 無 機 m 類 如 鹸 金 屬 如 鋰 納 和 鉀 土 金 K 如 鈣 和 m » 1 I 鹼 金 屬 氫 化 物 如 氫 化 鋰 和 氫 化 納 m 土 金 屬 氳 化 物 如 氲 1 1 化 m 金 屬 氫 氣 化 物 如 氫 氣 化 m 和 m 氣 化 押 m 金 羼 1 1 磺 酸 鹽 如 硪 酸 m 和 硪 酸 鉀 齡 金 靨 m 酸 £ 鹽 如 碩 酸 氫 納 和 硪 酸 氫 鉀 m 金 屬 烷 基 類 如 甲 基 鋰 烷 基 格 任 亞 試 麵 1 1 m 金 屬 醛 胺 類 如 化 胺 化 鋰 » 二 異 丙 基 胺 化 鋰 t 胺 化 m I 和 胺 化 鉀 金 屬 烷 氣 化 物 如 甲 醇 納 » 乙 酵 納 和 第 三 醇 1 1 鉀 鹼 金 靥 烷 鐽 酸 酯 9 如 乙 酸 納 1 m 土 金 靥 碩 酸 鹽 如 碩 i 1 酸 m 和 碳 酸 m ; 三 (低级)烷 基 胺 如 = 甲 胺 > 三 乙 胺 » N , N 1 | -二異丙基- N- 乙 胺 吡 啶 化 合 物 和 吡 啶 > 甲 吡 啶 * 二 甲 1 1 吡 綻 N , N- (低級) 院 胺 基 8 吡 啶 如 N , N - 甲 胺 基 毗 啶 9 1 1 1 1 1 i 本紙張尺度適用中國國家標準(CNS ) A4規格(2丨Ο〆297公釐) 460446 經濟部中央標準局負工消費合作社印製 修土 年 3 A7 B7 五、發明説明( 86. ~1 Γ, Of 啉 ; N- (低级)嗎啉如 N - (甲基)嗎啉 S , N- 二 (低级)烷 基 苄 胺 如 h , N - 二 甲 基 苄 胺 ; 及從二甲亞颯和氳化納或氳化鋰 製造之二甲亞现鹽類 較 佳 地 院 基 鋰 如 甲 基 鋰 和 正 丁基鋰 及 m 金 屬 醛 胺 類 如 胺 化 鋰 > 二 異 丙 基 胺 化 鋰 ), 然後 m 拌 所 得 混 合 物 〇 使 用 於 此 反 應 之 上 逑 m 的 蛋 沒 有 待 別 的 限 制 〇 通常, 該 使 用 於 毎 莫 耳 2 - 鹵 甲 基 氮 雜 環 丙 院 約 1 至 約 20莫耳 較 佳 1 . 5至 5 莫耳之比率。 反應溫度没有嚴格限制, 且 可 根 據 所 使 用 m 之 種 類 和 量 適 當 地 改 變 0 通 常 ,該反 應 適 合 於 約 -7 8 eC至约1 0 [TC範圍 較 佳 约 -78-C 至約 60"C 之 溫 度 進 行 1 且 於 此 條 件 下 該 反 應 可 於 約 10分鐘至數 天 完 成 〇 該 反 應 佳 進 行 於 惰 性 氣 體 如 氮 氣 或 氬 氣 之 流 中 〇 上 述 步 驟 産 生 具 良 好 産 率 之 式 U I I )化合物, 且該反應 液 體 可 以 其 本 身 使 用 於 随 後 之 步 驟 〇 若 需 要 的 話 ,藉由 將 反 應 液 體 進 行 習 知 純 化 調 整 如 蒸 餾 » 萃 取 » 洗 m ,溶 劑 蒸 發 * 及 管 柱 或 薄 層 層 析 可 單 離 和 純 化 該 式 (VII) 之 化 合 物 6 使 用 於 下 述 反 應 中 作 為 合 成 物 質 之 2 - 鹵 甲 基 雜環丙 烷 的 實 施 例 包 括 2 - 氣 甲 基 氮 雜 環 丙 院 i 2 - 溴 甲 基 氮雜環 丙 院 和 2- 碘 甲 基 氪 雜 環 丙 烷 0 該 等 化 合 物 根 據 下 列實施 例 1 或 1 中 所 述 方 法 從 市 面 上 之 稀 丙 胺 容 易 地 合 成。 步 驟 ) 於 此 步 驟 中 > 從 上 述 步 驟 (a )中所得式(V I I )之 1 -m雜 (請先閲讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) '4 6044 6 五 經濟部中央標準局工消費合作社印裝 2 /(N明说 明發 1.解 t分 琛劑 雙溶 A7 B7 K[IV 反t 酸 羧 舆 傜 烷 丁 行 進 物 合 化 得 所 且 式 成 化 轉 被 此 因 及 烷 丁 環 雜 氮 基 羥 - 3 之 溶呋 性氬 情四 應和 反醚 於乙 解二 溶如 先劑 首溶 物類 合醚 化之 I)述 VI所 Λα • /V 中驟 應步 反述 此上 於如 劑 C 匕 物::: 合(I 混式 該成 拌形 攪之 及逑 前 中 液 溶酸 得甲 所自 至 S 加地 酸當 羧適 將可 後酸 然羧 -述 中前 喃 如 和 該 。常 酸通 乙 〇 和制 酸限 甲的 為別 佳待 特有 。没 者董 酸的 機酸 有羧 的之 锤應 成反 加此 酸於 之用 物使 合 式 耳 莫 每 於 用 使 酸1. 羧佳 至 率 比 之 耳 莫 較可 ,且 耳 . 其制 20限 约格 至Μ 1 有 約设 物度 合溫 化應 I)反 根據所使用羧酸之種類和量適當地改變。通常,該反應 適合於約- 至约1〇〇»〇範圍•較佳约-78汜至约6(rc 之溫度進行,且於此條件下,該反應可於约10分鐘至數 天完成〇 該反慝較佳進行於惰性氣體如氮氣或氬氣之流中β 接著,以上述反應得到之化合物進行溶劑分解(如水 解),及因此可産生式(IV)之3-羥基氮雜琛丁烷。 該溶劑分解反應係藉由在水或醇類溶劑如甲醇,乙醇 和異丁醇或和有機溶劑如乙腈,四氫呋喃和二垮烷之混 合物中,及在如上述步躱(a )所述之適合齡或無機酸如 氣氛酸,£溴酸和氫碘酸存在下,於約- 2(TC至约51TC ,較佳在低如約0*C至室溫下處理該從上述反應得到之 化合物约1 0分鐘至數小時而進行。 若需要的話,S由將上述步思所得反應液醱進行習知 -1 0- 本紙張尺度適用中國國家標车{ CNS ) M規格(2丨0><297公釐) ^^^1 I I - - ^^^1 l 1* .¾ 、ve (請先閲讀背面之注意事項再填寫本页) 經濟部中央標準局員工消費合作杜印裳 A7 _____B7五、發明説明(9 ) 純化調整如蒸皤,萃取,洗滌,溶劑蒸發及管柱或薄 層層析,可單離和純化該式(IV)之化合物6然而無該單 離步驟,該反應液體可以其本身使用於随後之步驟中。 步睡frO 於此步驟中,從上述步《(b)中所得式(IV)之2-羥基 氮雜琛丁烷被轉化成式(III)之3-羥基- ΐ-(ι,3-喀唑啉 -2-基)氡雜琛丁垸。 此步驟可以下列方法(i)或(ii)進行: (i)上述轉化僳藉由將式(IV)3-羥基氰雜環丁烷輿以 下列式(V)表示之2-取代之ΡΪ唑啉衍生物在上述反窸惰 性溶劑(較佳為酵類溶S如甲酵或乙_)中,且較佳在上 迷適合餘如硪酸氳納,硪酸氫押,硕酸銷和硪酸押存在 下一起S拌而進行: nfl^l nn «Hi p - d^i ^ni TJ (請先閱讀背面之注意事項再填寫本頁) Νι (V) S, 其中L表離去基β 在上述式(V)化合物中以L表示之離去基的實施例包 括疊氮基;鹵原子如氦,溴和磺;低级烷酵镢基如乙醒 氣基和丙酵氣基;磺睡氣基如苯磺醯氣基,甲苯磺醯氣 基和甲磺醯氣基:低鈒烷氣基如甲氣基和乙氣基;及低 级烷硫基如甲硫基和乙硫基。其中特佳為低级烷硫基。 使用於此反應之齡和式(V)化合物的蛋沒有特別的限 制》通常,該鹾和式(V)化合物使用於每莫耳式(IV)化 1 1 - 本紙張尺度適用中國國家榡隼(CNS ) A4規格(210X297公釐) 13^ 4 6044 6 iL· ;i ίί A7 B7 五、發明説明 合物約1至約3莫耳,較佳約1至約1.5莫耳之比率。 反應溫度没有嚴格限制,且可根據所使用鹺和式(V)化 合物之種類和量適當地改變。然而,通常該反應適合於 室溫至約1G0T:範圍之溫度,較佳約室溫至約8Q°C進行 ,且於此條件下,該反應可於約1小時至約24小時完 成。 由適 藉述 。1^上中了流Y 氣r起 0 Η -如II鹽 氣{I酸 氘式氰. 如成硫 體化異 氣轉基 性物乙 惰合鹵 於化與 行V)物 進{1合 佳式化 較從V) 應1)(1 反(i式 將 三 如0 機 有 述 上 於 佳 較 且 中 腈 乙 於 佳 較 , 0 中下 _ 在 溶存 之胺 合乙 例異 施基 實乙 的碘 鹽和 酸鹽 氰酸 硫気 異硫 基異 乙基 鹵乙 之溴 料 -原鹽 為酸 作氰 明碕 發異 本基 。 於乙鹽 用氯酸 使括氰 包硫 別毎 5 恃於1. 有用約 S 使至 量鹽 1 的酸約 發氣佳 酸硫較 m 異 , 硫基耳 異乙莫 基鹵 3 乙和約 鹵il至 和該 1 鹺常約 之通物 0 , 合 反而化 此然V) 於。(I 用制式 使限耳 的莫 (請先閱讀背面之注意事項再填寫本頁). 經濟部中央標準局篇工消費合作社印裝 , 當 制適 限量 格和 嚴類 有種 C 沒之0°c 度鹽-2 溫酸约 應氛於 反硫合 α 異適 率基應 比乙反 之鹵該 耳和常 莫鹺通 約 至 成 完 時 小 數 至 約鐘 如分 低10 於約 用 -使而 所然 據 。 根變 可改 且地 佳 較 度 溫 之 圍 範This paper is again applicable to the Chinese National Standard (CNS) A4 specification (21 Ox 297 mm) printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 4 6 0 4 4 6 A7 B7 V. Description of the invention (了) In the above formula, R represents a leaven group, a substituted or unsubstituted lower alkyl or aryl group; and X represents a halogen atom. In the description, the term "lower" means the number of 硪 atoms, preferably 6 or less, preferably Is 4 or less. "Lower alkyl" may be a straight-chain alkyl group or a branched alkyl group. Examples include methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, and Di-butyl, tertiary-butyl, n-pentyl, isopentyl, n-hexyl, isohexyl, n-heptyl and isoheptyl. Of these, methyl, ethyl, n-propyl, and isopropyl are preferred. , N-butyl, isobutyl, second-butyl, third-butyl. In these cases, the lower alkyl group may be substituted by a phenyl group, and the benzyl group may be further substituted by at least one (preferably One or two diphenyl) hydrazone is substituted with a substituent consisting of a methyl group, a methyl group, an ethyl group, and a nitro group. The "fluorenyl group" may be a carboxyl moiety from an organic carboxylic acid group. Residual part of the hydroxyl group. Examples of aldehyde groups include lower alkyl groups such as acetoyl, propionyl and butyraldehyde, or substituted or unsubstituted benzoyl groups. "Aryl" may be mono- or Polycyclic, and Yu Chen may further have one or more substituents such as lower alkyl, nitro or halogen atom. Examples of aryl include phenyl, tolyl, xylyl, cr-lyl and S-Lacky. "Tooth Atoms" includes ", gas, bromine and iodine atoms, and among them preferably cyanide, molybdenum and iodine atoms. In the following, it is shown in Scheme 圏 (A) in detail according to each step ®. Method: (Please read the notes on the back before filling in this page) This paper size is applicable to Chinese National Standard (CNS) A4 specification (21 OX297 mm) 46044 6 A7 B7 Printed by the Staff Consumer Cooperative of the Central Bureau of Standards, Ministry of Economic Affairs 2. Description of the invention () 1 1 Step (a) 1 i In this step 9 the 2-halomethylazetidinyl group is reacted 1 1 > Therefore it is converted into 1 represented by formula (VII) -Azabicyclic C 1 .1 .0 ] -Μ- JI 丁 院 〇k, read 1 I read 1 I The above reaction proceeds as follows 1 1 Dissolve it 1 2 · Halomethylazepines are dissolved or suspended in the reactive alkaline blue. Note 1 ( The inert solvent is selected from the group consisting of fermented solvents such as methanol. Ethanol, propionate and normal matters 1 \ 1 1 Butyl fermented ether solvents such as diethyl ether and tetrahydrofuran 1 m solvents such as n-heptane%% ▲ hexane t-hexane »Shujiyuan 9 Wuyuan and Wuyuanyuan are soluble in solvents such as methyl acetate 1 esters and ethyl acetate: halogen solvents such as dioxane methyl compounds» Aeroform and tetranitride m 1 1 r or acetonitrile t dimethylformamide m amine dimethylacetamide 9 dimethyl acetone 1 I and the like preferably 9 m type solvents such as diethyl ether and tetramethylfuran), and 1 1 is suitably added to the obtained solution or m float ( The article is selected from organic or inorganic I Metals such as rhenium metals such as lithium sodium and potassium earth gold K such as calcium and m »1 I Alkali metal hydrides such as lithium hydride and sodium hydride earth metal halides such as osmium 1 1 m hydrogen hydrides such as hydrogenated m and m gas Chemicals such as sodium sulfonate and potassium osmium acid, etc. Salts such as sodium hydrogen sulfonate and potassium hydrogen sulfonate, metal alkyls such as methyl lithium alkyl Surface 1 1 m metal aldehyde amines such as lithium amidated »lithium diisopropyl aminated t aminated m I and potassium aminated metal alkane vapors such as sodium methoxide» sodium ethanoate and third alcohol 1 1 potassium alkali gold Pinane sulfonate 9 such as sodium acetate 1 m arsenic acid salt such as shuo i 1 acid m and carbonic acid m; tri (lower) alkylamines such as = methylamine > triethylamine »N, N 1 | -diiso Propyl-N-ethylaminopyridine compounds and pyridine > Methylpyridine * Dimethyl 1 1 Pyridine N, N- (lower) Amine 8 Pyridine such as N, N-Methylpyrimidine 9 1 1 1 1 1 i The size of this paper applies to Chinese National Standard (CNS) A4 (2 丨 〇〆297 mm) 460446 Printed by the Central Standards Bureau of the Ministry of Economic Affairs and Consumer Cooperatives for the Year of Repair 3 A7 B7 V. Description of the invention (86. ~ 1 Γ, Of morpholine; N- (lower) morpholine such as N- (methyl) morpholine S, N-di (lower) alkylbenzylamine such as h, N-dimethylbenzylamine; and from dimethyl The dimethyl arsenic salts produced by sulfonium and trihalide or lithium trihalide are preferably lithium bases such as methyl lithium and n-butyl lithium and m metal aldehyde amines such as lithium amines> diisopropyl amination Lithium), and then mix the resulting mixture. There is no other restriction on the eggs used for this reaction. Generally, this is used for about 1 to about 20 mols of mol 2 -halomethylazepine. A ratio of 1.5 to 5 moles is preferred. The reaction temperature is not strictly limited, and may be appropriately changed according to the kind and amount of m used. Generally, the reaction is suitable for about -7 eC to about 10 [TC range is preferably about -78-C to about 60 " C It is carried out at a temperature of 1 and under this condition, the reaction can be completed in about 10 minutes to several days. The reaction is preferably performed in a stream of an inert gas such as nitrogen or argon. The above steps produce a compound of formula UII with good yield. And the reaction liquid can be used by itself in the subsequent steps. If necessary, the reaction liquid can be subjected to conventional purification adjustments such as distillation »extraction» wash m, solvent evaporation * and column or thin layer chromatography can be isolated And purification of the compound 6 of formula (VII). Examples of 2-halomethylcyclopropane used as a synthetic substance in the following reactions include 2-methylaminoazapiridine i 2-bromomethylazapine Cyclopropane The compound is easily synthesized from dilute propylamine on the market according to the method described in Example 1 or 1 below. Step) In this step> 1-m miscellaneous formula (VII) obtained from the above step (a) (please read the precautions on the back before filling this page) This paper size applies the Chinese National Standard (CNS) A4 specification (210X 297mm) '4 6044 6 5 Printed by the Industrial Standards and Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 2 / (N clearly stated 1. Solution t fenchen agent double soluble A7 B7 K [IV trans t acid carboxamidine The marching compound is chemically obtained and the formula is converted to the solvent-soluble argon cyanide reaction of the cause and the alkanecycloazazine hydroxy-3, and the transether is dissolved in the second solution such as the first dissolve of the first solvent. ) Mentioned in VI Λα • / V The steps should be reversed, as described in the above agent C Dagger :: (I mixed type, mixed into the shape and mixed with the solution of the acid before dissolving the acid from S to the ground When the carboxylic acid is suitable, the acid will be followed by the carboxylic acid-as described in the previous paragraph. Often acidic acid and acidic acid are limited to the special treatment. The organic acid of the Dong acid has a carboxylic acid. Adding the acid to the compound makes the compound 1. Good rate to be more than the ear than, ear and its braking limit of about 20 cells to about Μ 1 is provided with a temperature of the object to be bonded of I) Anti changed appropriately depending on the kind and amount of carboxylic acid used. In general, the reaction is suitable for a range of about-to about 100 »°. • It is preferably carried out at a temperature of about -78 ° to about 6 (rc), and under this condition, the reaction can be completed in about 10 minutes to several days. This reaction is preferably carried out in a stream of inert gas such as nitrogen or argon β. Next, the compound obtained by the above reaction is subjected to solvolysis (such as hydrolysis), and thus 3-hydroxyazepines of formula (IV) can be produced. The solvolysis reaction is carried out in a mixture of water or an alcoholic solvent such as methanol, ethanol and isobutanol or an organic solvent such as acetonitrile, tetrahydrofuran and dipentane, and as described in step (a) above. A suitable age or an inorganic acid such as atmospheric acid, bromic acid and hydroiodic acid is treated at about -2 ° C to about 51TC, preferably at a temperature as low as about 0 * C to room temperature. The compound is carried out from about 10 minutes to several hours. If necessary, S is known by the reaction solution obtained from the above-mentioned Bu Si-1 0- This paper size applies to the Chinese national standard car {CNS) M specification (2 丨 0 > < 297 mm) ^^^ 1 II--^^^ 1 l 1 * .¾, ve (Please read the precautions on the back first (Write this page) The consumer cooperation of the Central Standards Bureau of the Ministry of Economic Affairs Du Yinshang A7 _____B7 V. Description of the invention (9) Purification adjustments such as steaming, extraction, washing, solvent evaporation, and column or thin layer chromatography, which can be isolated and purified However, the compound 6 of formula (IV) does not have the single separation step, and the reaction liquid may be used in the subsequent step itself. Step sleep frO In this step, formula (IV) obtained from the above step "(b)" The 2-hydroxyazepine butane is converted to 3-hydroxy-fluorene- (ι, 3-carazolin-2-yl) pyrazine butanidine of formula (III). This step can be carried out by the following method (i) Or (ii): (i) the above conversion is performed by converting 3-hydroxycyanobutane of formula (IV) to a 2-substituted oxazoline derivative represented by the following formula (V): In a solvent (preferably a yeast-based solution such as formazan or ethyl), and it is preferably mixed in the presence of acetic acid, sodium acetic acid, hydrogen acetic acid, hydrogen acid, and acetic acid. Perform: nfl ^ l nn «Hi p-d ^ i ^ ni TJ (Please read the notes on the back before filling this page) Νι (V) S, where L represents the leaving group β in the compound of formula (V) above Expressed by L Examples of the leaving group include an azide group; a halogen atom such as helium, bromine, and sulfonic acid; a lower alkanoyl group such as ethoxy group and propionyl group; a sulfonyl group such as benzenesulfonyl group, toluene Fluorenyl and methanesulfonyl: Low alkane groups such as methyl and ethyl groups; and lower alkylthio groups such as methyl and ethyl thio groups. Among them, lower alkylthio groups are particularly preferred. Used here There are no particular restrictions on the age of the reaction and the egg of the compound of formula (V). "In general, the compound of formula (V) and formula (V) are used for each mole of formula (IV). 1-This paper applies to Chinese national standard (CNS). A4 specification (210X297 mm) 13 ^ 4 6044 6 iL ·; i ί A7 B7 V. Invention description The composition is about 1 to about 3 moles, preferably a ratio of about 1 to about 1.5 moles. The reaction temperature is not strictly limited and may be appropriately changed depending on the kind and amount of the compound (X) and the formula (V) used. However, in general, the reaction is suitable for a temperature ranging from room temperature to about 1 GOT :, preferably from about room temperature to about 8Q ° C, and under this condition, the reaction can be completed in about 1 hour to about 24 hours. By appropriate borrowing. 1 ^ up in the flow Y gas r from 0 Η-such as II salt gas {I acid deuterium cyanide. Such as sulfurization of heterogeneous gas transesterification of acetal and halogenated compounds and line V) into {1 The reformation should be from V) should be 1) (1 inverse (i-form will be three as 0 machine is described on the better and middle nitrile is better than the better, 0 middle and lower _ in the case of dissolved ammonium acetone) The iodine salt of ethyl and the acid salt of thiocyanate isothioisoethyl haloethyl bromide-the original salt is acid as cyanocyanine, and the isocyanato group is used as the salt. The chloro acid is used to make the cyanosulfuryl group 5 in the ethyl salt. With about S, the amount of acid in the salt 1 is about 60%. The acid sulfur is different from that of m, the thiol isethoxy molybdenum 3, and the halogen is about 1 to the common thing 0, which is usually the same. This is V) Yu. (I use the standard to make the ears of Mo (please read the precautions on the back before filling this page). Printed by the Central Consumers ’Bureau of the Ministry of Economic Affairs and the Consumer Cooperatives. Species C 0 ° C Degree salt-2 Warm acid should be around the desulfurization α The isoproperty base should be 10 times lower than the second half of the halogen and the regular mole to the completion of the decimal to 10 minutes to With - and so the data then becomes the root and can be changed relatively good temperatures of around Fan
-7 進 溫 室 至 'C 氣 性 惰 於 »1 行 ί 進法 佳方 較行 應遠 反可 或 於 可 li 反 該 下 件 條 此 於 且 中 流 之 氣 氬 或 氣 氮 如 體 0 反 話 的 要0 若0 - 何 任 本紙張尺度適用中國國家標準(CNS ) Α4規格(210乂297公釐) 4 6044 6 經濟部中央標準局員工消費合作社印製 A7 _______B7___五、發明説明(") 液醱可進行習知純化調整如蒸脯,荦取,洗雎,溶劑蒸 發,及管柱或薄層層析,然後可箪離和纯化該式<ιιη 之化合物。再者,當舆有機及無機酸(其如上所述於逋 合溶劑中形成式(I)化合物之酸加成鹽)一起攪拌時,該 UII)可以酸加成鹽單離。 製備於上述方法中之式(ΙΙ:Π化合物葆為任何其他文 獻未曾提過之新穎化合物,且構成本發明之一部扮· 步 a (ri) 於此步驟中,從上迷步驟(c)中所得式(III)之3-羥基 -1-(1,3 -喀唑啉-2-基)気雜琛丁烷被轉化成式(II)之卜 统基-1-(1,3-咩唑啉-2-基)氟雜瓖丁烷衍生物。 此步驟可以下列方法(i)或(ii)進行: (i)上逑»化可藉活化式(III)化合物之羥基,之後使 所得經活化之衍生物與式RSH(其中R如上述定義)表示 之化合物或與其鹽反應。 式RSfl表示之硫酵化合物的實施例包括硫乙酸,硫丙 酸,硫苯甲酸,第三-丁基硫酵,苯甲基硫酵,二苯甲 基硫醇,三苯甲基硫酵,其中苯基被一匍或二«羥基* 甲氣基,乙S «基,或硝基取代之苯甲基硫酵f被低级 烷基,硝基或鹵原子取代之苯硫酵,或萊酵。其中較佳 為其中K表低级烷醯基或經取代或未經取代笨醯基之 醇化合物。再者,該硫酵化合物可於舆齡金颺如納和押 之S形式。 該活化式UII)化合物之羥基的反應可藉由将式Π11) -1 3- I----------裝------訂------^ ^ (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(2!〇ΧΜ7公釐) 4 6 0 4 4 6 1£ 修 明説 明發 ' 五-7 Enter the greenhouse to 'C. Gas inertia is less than »1 line. The method of advancing is better or farther. Or you can defer to the next article. The medium-term gas argon or nitrogen is like 0. Yes 0 If 0-Any paper size applies Chinese National Standard (CNS) A4 specification (210 乂 297 mm) 4 6044 6 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 _______B7___ 5. Description of the invention (") The liquid mash can be subjected to conventional purification adjustments such as steamed preserves, extraction, washing, solvent evaporation, and column or thin layer chromatography, and then the compound of the formula < ιιη can be isolated and purified. Furthermore, when organic and inorganic acids (which form an acid addition salt of a compound of formula (I) in a coupling solvent as described above) are stirred together, the UII can be isolated by the acid addition salt. The formula (II: II compound 制备) prepared in the above method is a novel compound not mentioned in any other literature and constitutes part of the present invention. Step a (ri) In this step, from step (c) above 3-Hydroxy-1- (1,3-carazolin-2-yl) pyridinium butane of formula (III) obtained in the above is converted into oxidyl-1- (1,3-oxazole) of formula (II) Phenolin-2-yl) fluoroheterobutane derivative. This step can be carried out by the following method (i) or (ii): (i) the hydration can be activated by activating the hydroxyl group of the compound of formula (III), The activated derivative reacts with a compound represented by the formula RSH (where R is as defined above) or a salt thereof. Examples of thiol compounds represented by the formula RSfl include thioacetic acid, thiopropionic acid, thiobenzoic acid, and tert-butylthio Fermentation, benzyl thiol, benzhydryl thiol, trityl thiol, in which the phenyl group is substituted by one or two «hydroxy * methylamino, ethyl S«, or nitro Thiolase is substituted by lower alkyl, nitro, or halogen atoms, benzenesulfonate, or lysozyme. Of these, the alcoholization of lower alkyl alkyl or substituted or unsubstituted benzyl is preferred. In addition, the thiol compound can be used in the form of S and Y. The activated hydroxyl group of the UII compound can be reacted by the formula Π11) -1 3- I ----- ----- Installation ------ Order ------ ^ ^ (Please read the precautions on the back before filling this page) This paper size is applicable to China National Standard (CNS) A4 specification (2! 〇 ΧΜ7mm) 4 6 0 4 4 6 1 £ Revision instructions issued '5
V 年 S5. ft 和乙 氛像 酷劑 磺溶 甲性 如惰 劑述 化上 活於 基行 羥進 之氣 鹵睡 醛乙 磺如 機氯 有酵 像或 種氣 一 0 與磺 物苯 合甲 化4- 0 « 合吡 適基 述胺 上甲 於二 佳S-較Κ, 且和 ,胺 中乙 喃基 呋丙 氫異 。 四二下 和,在 Μ胺存 乙乙之 二三物 如如合 劑鹾組 溶機其 類有或 醚像 , 物制Γ 合 限b 的:T 別II 特(I 有式 ϊδ耳 蛋莫 的每 劑於 化用 活使 基劑 羥化 和活 鹺基 之羥 慝和 反驗 此該 於 , 用常 使通 率 比 之 耳 莫 約 之 ί 20 - 化约 活於 和合 鹺適 用應 使反 1.所該 约據常 至根通 1 可 , 約且而 佳,然 較制。 ,限變 耳格改 莫薛地 3 有當 約S適 至度量 1 溫和 约應類 反 種V years S5. Ft and acetonitrile, sulphur-solubilizing properties, such as inert agents, and alkaloid aldehyde, acetaldehyde, sulfonyl sulfonate, etc., such as organic chlorine, have a fermented image or seed gas. The methylation of 4- 0 «bispyridyl amine is better than that of Erjia S-, which is different from that of ethanylfuranil in amines. Forty-two, and two, three, two, three, two, three, two, three, two, three, two, three, two, three, two, two, and three, such as the mixture of 鹾, 溶, 溶, 溶, 醚, 醚, 醚, 限, 限, 耳, 耳, 蛋, 蛋Each dose is used to make the base hydroxylate and the hydroxyl radical of the active base and the reverse should be done, and the flux rate is often inferior to that of the ear. 20-Reduce the liveness of the active ingredient. The covenant is often based on Gentong1, which is better and better, but less compelling. The limited-variable ear lattice is modified to Moxuedi3. When the covenant S is appropriate to measure 1, the mild covenant should be the opposite.
C (請先聞讀背面之注意事項再填寫本頁)C (Please read the notes on the back before filling this page)
一了 /ίι 進 度 溫 之 溫 室 至 "C 成 完 時 小 數 至 约鐘 如分 低10 在约 佳應 較反 圍下 範形 ρ 情 50該 約於 至及 中 流 之 氣0 或 f I 氣 I * J T1 fcw ( 如式 體之 氣化 性活 惰被 於已 行基 進羥 佳將 較 , 應後 反然 拌 攪 起 一 鹽 其 或 物 合 化 之 示 表 式如 以劑 述·溶 上之 與合 物適 合述 化上 η於 式 之 要 所 得 獲 可 中 步 此 於 欲 此 如 中 胺0 甲 〇 基物 甲合 二化 量 的 鹽 其 或 物 合 化 酵 硫 之 示 表 Ε S R 以 之 應 反 此 於 用 使 經濟部中央標隼局負工消費合作社印製 耳其 其 CO 毎至 於1 用佳 使較 0 , 其耳 或莫 物 00 合約 化至 該 1 .約 常物 通合 〇 化 制之 限化 的活 別被 特已 有基 沒羥 餘適 用應 使反 所該 據 , 根常 可通 且 〇 ,變 制改 限地 格當 磨適 有量 沒和 度類 溫種 應之 反物 。 合 率化 比醇 之硫 耳和 约行 於進 合度 時 小 數 至 12鐘 约分 至10 溫約 室於 約可 佳應 較反 -該 圍 , 範下 Ρ 件 50條 I此 於 且 約 至ρOne / ίι The temperature of the greenhouse to " C When the completion is completed, the decimal to the clock is as low as 10 cents. In the best, it should be better than the surrounding pattern. Love 50, which should be about to the middle of the air 0 or f I gas I * J T1 fcw (For example, the gasification activity of the formula body is better compared with the hydroxyl group that has already been formed. After the reaction, the salt is mixed or the compound is shown in the formula. The compound is suitable for formulating η in the formula to be obtained. The intermediate step is as shown in the table below. The amount of the salt of the amine 0 methyl group or the amount of the compound is shown in the table. E SR Instead, use the CO of the Central Bureau of Standards of the Ministry of Economic Affairs to print the ears of its CO 毎 to 1. Use better than 0, and its ears or mou 00 will be contracted to 1. The normal thing will be combined. The limitation of the system is limited by the existence of the existing bases, which should be used to counteract the reasons. The roots are often accessible and 0, and the system should be modified to limit the amount of material and temperature. The combination ratio is smaller than that of the alcohol's thiol and approx. From about 12 minutes to bell to about room temperature to about 10 can best be compared with trans - the Wai, Ρ member 50 to and from about I to this lower range ρ
溫 之 •C 本紙張尺度適用中國國家標準(CNS ) Α4规格(210 X 297公釐) 4 6 0 44 6 五、發明説明Wen Zhi • C The paper size applies to Chinese National Standard (CNS) Α4 specification (210 X 297 mm) 4 6 0 44 6 V. Description of the invention
A7 B7 經濟部中央榡隼局負工消費合作杜印製 完成。 該反應較佳處理於惰性氣體如氮氣或氬氣之流中。 (ii)式(III)化合物轉化成式(II)化合物亦可藉由使 式(III)化合物與二(低鈒 > 烷基偶氮二甲酸鹽,三苯基 瞵及上迷以RSH表示之化合物反應而進行。 使用於本發明之二(低级)烷基偶氮二甲酸鹽的實施例 包括二乙基偶氮二甲酸鹽和二異丙基偶氪二甲酸鹽。如 為以RS Η表示之化合物,其可使用如上述(i)中所述者。 該反應亦藉由將式(III)化物與二(低鈒)烷基偶氮二甲 酸鹽,三苯基_及上逑以RSH表示之化合物一起!ft拌於 上逑適合之溶劑像_類溶劑如二乙班和四氫呋喃中而進 行。 使用於此反應之二(低级)烷基偶m二甲酸鹽,三苯基 睇及上述以RSH表示之化合物的量沒有特別的限制.。然而 ,通常該等化合物使用於每莫耳式(III)化合物约1至 約3莫耳,較佳约1至約2契耳之比率。反應溫度沒有 睹格限制,且可根據所使用試劑和化合物之種類和量適 當地改變《然而,通常該反應適合於約- 2trc至約50°C 範圍之溫度,較佳約o°c至室溫進行,且於此條件下, 該反應可於約約10分鐘至數小時完成。 反應較佳進行於惰性氣體如氮氣或氬氣之流中。 使用方法(i)或Ui)任何一値,若需要的話,反應液醴 可進行習知純化調整如蒸餾,萃取,洗滌,溶劑蒸發, 及管柱或薄層層析,然後可單離和純化該式(II)之化合 -15- 本紙張尺度適用中國國家標準(CNS ) A4规格(210X297公釐) ^^1. -1- - I i 1 - _ I I —1 i ^^^1 [ ^1J 、-tl (#先閱讀背面之注意事項再填寫本頁) 4 6044 6 A7 B7 經濟部中夬標率局員工消費合作社印製 五、發明説明 (^ ) 1 1 物 e 再 者 t 當 與 上 述 有 機及 無檐酸於 適合 溶麵中一起 攪 1 1 拌 時 • 該 (I I) 可 以 酸 加 成鹽 單_。 1 t 如 此 所 得 之 式 (I η化 合物 亦為任何 其他 文獻末曾提 過 請 1 1 | 之 新 穎 化 合 物 f 且 構 成 本發 明之一部 份。 先 閱 I I 讀 1 步 騮 ) 背 面 1 | 於 此 步 驟 中 I 從 上 逑 步驟 (d )中所得式( II)之2-魏基- 之 注 意 1 1 1- (1 ,3 -瞎唑啉- 2- 基 )«雜環丁烷衍生物或其酸加鹽, 事 項 I \ 由 其 ,被 再 1 » ϋ 從 中 裂 解 掉 R 基 轉化成本 發明 式(I)之3-S f 裝 基 -1-( 1, 3- Ilf 唑 -2 -基)氮 雜琛丁烷 衍生 物或其醴加 成 尽 頁 1 鹽 〇 1 | 可 藉 由 上 述 溶 劑 分 解 反應 如水解作 用, 或藉由下列 U 1 1 解 反 應 將 該 R 其 裂 解 〇 1 1 氳 解 作 用 可 藉 由 將 式 U I )化合物處 理於 ,例如PH5- 7 訂 I 之 缓 衝 溶 液 如 乙 酸 豔 後 衝溶 液,嗎福 啉基 丙磺酸篇- 氫 1 | 氣 化 m 緩 衝 溶 液 該 等 缓衝 溶液和酵 類溶 繭之混合溶 劑 1 1 , 或 混 合 溶 m 如 四 氳 呋 喃- 水,四氫 呋喃 •乙酵-水, 二 1 I 烷 水, 二吗院- 乙 酵 -水, 和丁酵- 水(各包含磷Μ二 k m , 磺 酸 氳 m t 等 等 ) 使用约1至4 at· 之氫,在氫 化 1 1 觸 媒 如 氣 化 鉑 S 氣 化 耙 -活性磺酸氫氣化把-活性硪存 在 I 下 9 在 約 〇°C至約50*C範函之溫度進行約0 • 2 5至约5小 1 時 0 1 1 上 述 步 驟 産 生 具 良 好 産率 之本發明 式(I )化合物。若 ! I 需 要 的 話 由 將 該 反 應 液醱 進行習知 純化 諝整如蒸皤 1 1 萃 取 » 洗 滌 1 溶 劑 蒸 發 ,及 管柱或薄 層層 析,可單離 和 I 1 -16- 1 1 1 1 本紙張尺度通用中國國家標準(CNS } A4規格(21 OX 297公釐) 460446 · A7 B7五、發明説明(β ) 純化該式(I )之化合物》 方法铮化B : 於第二個建議之方法中,該化合物(I)换從式(VII)化 合物(其可«由上述方法從2-鹵甲基氮雜琛丙烷製锵i以 下列流程圏(B)所示之反應路徑製備。 流诨匾(mA7 B7 Du printed the work of the Central Government Bureau of the Ministry of Economic Affairs. The reaction is preferably treated in a stream of an inert gas such as nitrogen or argon. (ii) Conversion of a compound of formula (III) into a compound of formula (II) can also be achieved by combining a compound of formula (III) with bis (low fluorene) alkyl azodicarboxylate, triphenylsulfonium and RSH The compound represented by the formula is reacted. Examples of the di (lower) alkylazodicarboxylate used in the present invention include diethylazodicarboxylate and diisopropylazodicarboxylate. Is a compound represented by RSΗ, which can be used as described in (i) above. The reaction is also carried out by combining a compound of formula (III) with a bis (lower) alkyl azodicarboxylate, triphenyl _ Together with the compound represented by RSH in the above formula! Ft is mixed with suitable solvents in the formula like _ solvents such as diethylban and tetrahydrofuran. The second (lower) alkyl dimethane diformate used in this reaction There is no particular limitation on the amount of triphenylphosphonium and the above-mentioned compound represented by RSH. However, these compounds are usually used in an amount of about 1 to about 3 moles, preferably about 1 to about 3 moles per mole of the compound of formula (III). The ratio of 2 deciles. The reaction temperature is not limited and can be appropriately determined according to the type and amount of reagents and compounds used. However, in general, the reaction is suitable for a temperature in the range of about -2 trc to about 50 ° C, preferably about o ° c to room temperature, and under these conditions, the reaction can be completed in about 10 minutes to several hours. The reaction is preferably performed in a stream of inert gas such as nitrogen or argon. Using either (i) or Ui), if necessary, the reaction solution can be subjected to conventional purification adjustments such as distillation, extraction, washing, solvent Evaporation, and column or thin-layer chromatography, then the compound of formula (II) can be isolated and purified -15- This paper size applies to China National Standard (CNS) A4 specification (210X297 mm) ^^ 1. -1 --I i 1-_ II —1 i ^^^ 1 [^ 1J 、 -tl (#Read the precautions on the back before filling this page) 4 6044 6 A7 B7 Printed by the Employees' Cooperatives of the Bureau of Bid Rates in the Ministry of Economic Affairs Preparation 5. Description of the Invention (^) 1 1 物 e Moreover t When mixed with the above organic and eucalyptus acid in a suitable noodle mixture 1 1 • The (II) can be acid-added salt list _. 1 t thus obtained (I η compound is also the novel compound f of 1 1 | at the end of any other literature and constitutes a part of the present invention. Read II read 1 step 骝) Back 1 | At this step In the formula I, the 2-Weiyl group of the formula (II) obtained from the step (d) above is noted 1 1 1- (1,3-Brazazoline-2-yl) «heterobutane derivative or its acid Adding salt, matter I \ From this, it is further 1 »ϋ from which the R group is cleaved to convert it to 3-S f in the formula (I), which is charged with 1- (1, 3- Ilfazole-2 -yl) aza The butan derivative or its hydrazone addition is complete 1 salt 〇1 | The R can be cleaved by the above solvolysis reaction such as hydrolysis, or by the following U 1 1 decomposition reaction. By treating the compound of formula UI), for example, a buffer solution of PH5-7 and I, such as an acetic acid backwash solution, morpholinopropanesulfonic acid-hydrogen 1 | gasification m buffer solution Equally buffer solution and mixed solvent of fermented cocoon 1 1, or mixed solvent such as tetrahydrofuran-water, tetrahydrofuran · acetase-water, di 1 I alkane water, dimorphin-acetase-water, and Ding Fermentation-water (each containing 2km of phosphorus, sulfonium sulfonate, etc.) using about 1 to 4 at · hydrogen, hydrogenating 1 1 catalysts such as vaporized platinum S gasification rake-active sulfonic acid hydrogenation- Active fluorene is present in the presence of I at a temperature of about 0 ° C to about 50 * C for about 0 • 2 5 to about 5 hours 1 hour 0 1 1 The above steps produce compounds of formula (I) of the invention in good yield . If! I need to perform conventional purification of the reaction solution if necessary, such as steaming 1 1 Extraction »Wash 1 Solvent evaporation, and column or thin layer chromatography, can be isolated and I 1 -16- 1 1 1 1 The paper size is in accordance with the Chinese National Standard (CNS) A4 (21 OX 297 mm) 460446 · A7 B7 V. Description of the invention (β) Purification of the compound of formula (I) "Method B: In the second suggestion In the method, the compound (I) is replaced with a compound of the formula (VII) (which can be prepared by the above-mentioned method from 2-halomethylazepinepropane (i) by the reaction route shown in the following scheme (B). Stream plaque (m
N (vn) (a) S=< HN-N (vn) (a) S = < HN-
r—N X)^-S—< ,NH (VI) (b) _ — 訂 (請先閲讀背面之注意^項再填寫本頁) 經濟部中央標準局|工消費合作杜印裂r—N X) ^-S— <, NH (VI) (b) _ — Order (Please read the note on the back ^ before filling this page) Central Bureau of Standards, Ministry of Economic Affairs
Ν N—i α) 於下文中,根據各步驟詳細地説明流程圓(B)顯示之 方法: -17- 本紙張尺度適用中國國家揉準(CNS ) A#規格(210X297公釐) 經濟部中央標隼局員工消費合作杜印製 460446 A7 B7五、發明説明(4 ) 步皤U) 於此步驟中,藉由使式(VII)之1-氪雜雙琛〔1.1.0〕 丁烷與1,3-瞜唑啭-2-硫_反匾而製備式(VI)之2·(氮雜 環丙-3-基硫基)-1,3-咩唑啉β 可藉將由式(VII)之1-«雜燹環〔1.1.0〕丁烷與-1,3-咩脞啉-2-硫明攪拌於上述適合之溶劑如(較佳為四氫呋 喃)中且較佳於像齡金屬氫化物和氫化鈉或鐮土金羼烷 氣化物和甲醇納進行此反應。 使用於此反應之1,3-咩唑啉-2-硫酮和鹼的量设有待 別的限制。通常,其各使用於每莫耳式(VII)之卜®雜 雙琿[1.1.0〕丁烷約1至约3契耳,較佳约1至约1.5 其耳之th率。反應溫度沒有駸格限制,且可根據所使用 1,3-JI唑啉-2-硫酮和鑣之種類和量逋當地改變。通常, 該反應適合於約-78 Τ至約1G(TC範園之溫度,較佳-78 °C 至室溫進行,且於此條件下,該反蠹可於約1小時至24 小畤完成。 反應較佳進行於惰性氣體如氮氣或氬氣之流中β 上述步驟産生具良好産率之本發明式UI)化合物,藉 由將該反應液體進行習知純化調整如蒸皤,萃取,洗滌 ,溶劑蒸發,及管柱或薄層層析,可軍離和純化該式(VI) 之化合物。再者,當與上述有機及無機酸於適合溶劑中 一起攪拌時,該(VI)化合物可以適合之酸加成賨單離。 所得之式(VI)化合物係為任何其他文獻未鳕提過之新 穎化合物,且構成本發明之一部份β -1 8 - " 裝 訂·" (請先聞讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標率(CNS ) Α4規格(210x297公釐)Ν N—i α) In the following, the method of displaying the circle (B) will be described in detail according to each step: -17- This paper size is applicable to China National Standard (CNS) A # specification (210X297 mm) Central standard of the Ministry of Economic Affairs The consumer cooperation of the Bureau of Staff Du Yinhua 460446 A7 B7 V. Description of the invention (4) Step 皤 U) In this step, by using the formula (VII) 1-doped Shuangchen [1.1.0] butane and 1 2,3-oxazolyl-2-sulfide_inverse plaque to prepare 2 · (azetidin-3-ylthio) -1,3-oxazoline β of formula (VI) can be obtained by formula (VII) The 1- «heterofluorene ring [1.1.0] butane and -1,3-pyridin-2-thiamine are stirred in a suitable solvent such as (preferably tetrahydrofuran) and preferably hydrogenated as the image age This reaction is carried out with sodium hydride or fusarium pinane gaseous vapor and sodium methoxide. The amounts of 1,3-oxazoline-2-thione and base used in this reaction are set to be subject to other restrictions. Generally, each of them is used at about 1 to about 3 decibels, preferably about 1 to about 1.5 deciles per mole of ()) heterobipyrene [1.1.0] butane. The reaction temperature is not limited by lattice, and may be locally changed according to the kind and amount of 1,3-JIazoline-2-thione and fluorene used. Generally, the reaction is suitable to be performed at a temperature of about -78 T to about 1G (TC Fanyuan, preferably -78 ° C to room temperature, and under this condition, the reaction can be completed in about 1 hour to 24 hours. The reaction is preferably performed in a stream of inert gas such as nitrogen or argon β. The above steps produce compounds of the formula UI) of the present invention with good yields. The reaction liquid is subjected to conventional purification adjustments such as steaming, extraction, washing Solvent evaporation and column or thin layer chromatography can isolate and purify the compound of formula (VI). Furthermore, when the organic and inorganic acids are stirred together in a suitable solvent, the compound (VI) may be subjected to suitable acid addition fluorene isolation. The obtained compound of formula (VI) is a novel compound not mentioned in any other literature and forms part of the present invention β -1 8-" Binding · " (Please read the precautions on the back before filling (This page) This paper size applies to China National Standards (CNS) Α4 size (210x297 mm)
4 6 0 4 4S A7 B7 五、發明説明(V ) 難 步 式 得 所 中 \/ β /1- 思 步 述 上 從 中 驟 步 此 於 雜 氮 /1% 2 之 本 -3據 丁根 環成 基 硫 基 式 明 發 化slm 被丨 此 ] 2 因 I 及啉 ,唑 理if 處3- 酸 1 /V 1 -與T 啉基 唑铕 咳3-3-之 基 式 述 上 將 • 由 烷將 丁藉 環可 雜 迷 上 於 拌 攪 酸 種1 與 物 合 化 之 括 包)o 例者 施鹽 實成 之加 酸酸 述成 上形 \Jr o I 喃與 快述 氫所 四上 為如 佳其 較ί (¢酸 劑機 溶無 之和 合機 適有 使 其 常 〇 通 酸 。 磺制 甲限 如的 酸別 磺待 基有 烷Ϊ9 级量 低的 為酸 者之 用應 使反 所此 佳於 較用 中使 其 制 限 格 0 有 OSES 约度 物溫 合應 化反 «1/ I ο (V率 式比 耳之 莫耳 每莫 於 1 用約 約 至 耳 契 佳 較 <诗先閱讀背面之注意事項再填寫本頁) 裝. 至所 .1據 nj 根 可 且 常 通 〇 變 改 地 當 迪 量 和 類 種 之10 酸約 用至 使溫 度 溫 之 圍 範 p 至 组 室 佳 較 室 於 合 適 應 反 該4 6 0 4 4S A7 B7 V. Description of the invention (V) Difficult to get in the way \ / β / 1- From the description of the step, this step is heteroaerobic / 1% 2 The basis -3 is based on the ring of sulfur The basic formula of the chemist ’s slm is 丨 this] 2 due to I and phthaloline, oxali if at 3-acid 1 / V 1-and T phosphonozole cough 3-3- The general formula is described by It can be mixed with the acidic acid 1 and the combination of the materials) o For example, the salt is added to the acid and the acid is described into a shape \ Jr o I, and the hydrogen is better It is more suitable for making acidity than organic solvent-free and acid-free machines. It is usually acidic. The acid of sulfonyl formazan is sulfonyl, which has a low level of alkane. The use of acid is low. It is better than using it to make the limit 0. It has OOSE, and the temperature of the material should be adjusted. «1 / I ο (V-rate-type mole of Mo Er is more than about 1 per ear. (Please read the notes on the back and fill in this page again.) Packing. To the best. 1 According to nj roots and can often be changed. The amount of 10 acid and the amount of 10 kinds of acid are used to make the temperature around the temperature. p good compared to the plurality of cells in the chamber should be appropriate to the trans
於 且 行 •ri 1P 中 。流 成之 完氣 時氬數氣 至氰 鐘如 分體 10氣 約性 於惟 可於 應理 反處 該佳 ,較 下應 件反 條該 此 物 合 化 皤 蒸 如 整 0 (I化 式純 之知 率習 産行 好進 良黼 具液 生應 産反 驟將 步由 述藉 上 , 話 的 要 霈 若 取 萃 經濟部中央標準局員工消費合作杜印製 滌丨法 洗式方 該 化 純 和 離 單 可 析 層 « 薄 或 柱 管 及 發 蒸 劑 溶 物 合 化 之 Θ 式 從 换 TX /1. 物 合 化 該 中 法 方 之 議 1 個三 第 於 備 製 烷 丙 環 雜 氮 基 〇 甲備 鹵製 2-徑 從路 法fi 方反 述示 上所 由C) /1 籍^ 0 可 程 Μ ί Θ流 物列 合下 化以 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X29?公釐) 460446 Α7 Β7 五、發明説明(θ 流稃圃(ηIn and line • ri 1P. At the completion of the flow, the argon gas is reduced to the cyanocyanide, such as the split 10, and the gas is about as good as it should be, but it should be treated better than the next application. Pure knowledge rate, good practice, good production, good liquid production, and the reverse steps will be borrowed. If you want to extract the consumption cooperation of the Central Standards Bureau of the Ministry of Economic Affairs, the printing and washing methods should be used. Purification and separation of analyzable layers «Thin or column tube and evaporating agent solution to combine the Θ formula from TX / 1. The combination of Chinese and French methods Nitrogen-based methyl chloride prepared from 2-methods from the road method fi side C) / 1 ^ ^ 0 可 程 Μ ί Θ The stream is combined to apply the Chinese National Standard (CNS) Α4 on this paper scale Specifications (210X29? Mm) 460446 Α7 Β7 V. Description of the invention (θ 流 稃 园 (η
(VII ) (a)(VII) (a)
VV
HSHS
X)NH (VIII) (b)X) NH (VIII) (b)
HS o :/s」 (i) 經濟部中央標準局員工消費合作社印製 於下文中,根據各步驟詳細地說明以流程豳(c)顯示 之方法。 步 g (a ) 於此步驟中,式(νΊ I)之1-氮雜雙琛〔1.1.0〕丁烷轉 化成式(VIII)之3 -魏基If唑啉β 可藉將由式(VII)之化合物與前逑以式RSH表示之化合 ··介 物或其鹽攪拌於上述適合之溶劑中,然後從所得化合物 中裂解掉R基而進行〇 . 式RSH表示之化合物或基锂的實施例包括上述之化合 物。其中所使用之較佳者為ϋ基表低级烷匿基或經取代 _ ,"r (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準{ CMS ) A4规格(210X297公釐) 4 60446 A7 B7 經濟部中央標率局負工消費合作社印製 五、發明説明(Μ ) 或未經取代之苯醯基,或其與鈉和鉀之鹽β 使用於此反鼴中與式(VII)反應之式RS Η表示之化合物 或其玀的置沒有特別的限制。通常,其各使使用於毎莫 耳式(VII)之化合物約1至約5其耳,較佳約1至3莫耳 之比率。反窸溫度沒有鼗格限制,且可根钂所使用式RSH 化合物的種類和量適當地改變。通常,該反應適合於約 -78BC至約βΟΤ範鼷之溫度,較佳- 50*C至室溫進行,且 於此條件下,該反鼴可於約10分鐘至數小時完成。 反應較佳進行於惟性氣醱如氮氣或氬*之流中。 接著,從上述反應所得之化合物裂解掉R基的反懕可 根據上述方法變A化步《(e)中所示之方法進行。 附帶地,當上逑反應你使用其R基為醯基之硫酵化合 物作為起始物而進行時,於瓌境(#見:後文所述之實施 例9)下加入2其耳當量之R甚至式(VII)化合物中.。然而 ,於此情況該R基亦可根據化上述方法變A之步《(e)之 步驊中所示方法被裂解掉(參見後文所述之實施例10)。 上述步驟産生具良好産率之式(VIII)化合物β若霈要 的話,藉由將該反應液體進行習知純化調整如蒸皤,萃 取,洗滌,溶劑蒸發,及管柱或薄層層析,可軍離和純 化該式(VIII)之化合物。再者,當與上述有機及無機酸 於適合溶劑中一起攪拌時,該(VIII)化合物可以適合之 酸加成邇軍離β m fb) 於此步《中,從上述步》(a)中所得式<VIII)化合物 -2 1 - (請先閱讀背面之注意事項再填寫本頁) 裝· 訂 本紙張尺度適用中國國家榡準(CNS ) A4#L格(210X297公釐) 4 60446 __;1 .I B7_ 五、發明説明IfA) ^3’ 2铲 與上述式(V)之2-經取代-1,3-瞜唑啉衍生物反醢而製備 根據本發明式(I)之化物。 此步驟如上述方法變化A中步思(C)之方法(i)或(ii) 之相同的方法進行。 使用方法(i)或(ii)任何一個,若需要的話,反應液 體可進行習知純化調整如蒸皤,萃取,洗滌,溶劑蒸發 ,及管柱或薄層層析,然後可單離和純化該式(I)之化 合物。 當與上述有機及無機酸於適合溶劑中一起携拌時,該 從上述方法變化A至C所得之式(I)化合物可以酸加成鹽之 形式單離。如此所得之酸加成鹽中(特別是氢氣酸鹽)可 容易地得具有如下述實施例所示之優異儲存安定性的结 .晶型式,非常適合於作為長期儲存之中間體。 如下列實施例13中所詳逑,當使用本發明所提供之式 (I)化合物依照下述流程圖(D),可獲得具良好産率之式 (IX) 碩配念化合物,其傜具有優異之抗菌活性且 其當其酯化後可口服施藥。 I 裝 f ^ (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局負工消費合作社印製 -2 2- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 460446 A7 B7 五、發明説明(w ) 流稈圔(D)HS o: / s ”(i) Printed by the Consumers' Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. In the following, the method shown in flow 豳 (c) is explained in detail according to each step. Step g (a) In this step, 1-azabischen [1.1.0] butane of formula (νΊI) is converted into 3-weiyl Ifazoline β of formula (VIII). The compound of the above formula is compounded with the compound represented by the formula RSH · The mediator or a salt thereof is stirred in the suitable solvent, and then the R group is cleaved from the obtained compound to perform the compound represented by the formula RSH or the lithium group. Examples include the compounds described above. Among them, the better one is fluorene-based lower alkyl or substituted _, " r (Please read the precautions on the back before filling this page) This paper size is applicable to Chinese national standard {CMS) A4 specification (210X297 (Mm) 4 60446 A7 B7 Printed by the Consumers ’Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the Invention (M) or unsubstituted phenylfluorenyl, or its salt with sodium and potassium β is used in this reaction There is no particular limitation on the arrangement of the compound represented by the formula RS 反应 or the 猡 thereof which reacts with the formula (VII). Generally, they each have a ratio of about 1 to about 5 moles, preferably about 1 to 3 moles, of the compound used in mol (VII). The reaction temperature is not specifically limited, and may be appropriately changed depending on the kind and amount of the compound of the formula RSH used. Generally, the reaction is suitable for a temperature of about -78BC to about β0T range, preferably -50 * C to room temperature, and under these conditions, the reaction can be completed in about 10 minutes to several hours. The reaction is preferably carried out in a stream of unique gas such as nitrogen or argon *. Next, the reaction of cleavage of the R group from the compound obtained by the above reaction can be carried out according to the method shown in Step A ("(e)"). Incidentally, when the above reaction is performed using a thiol compound whose R group is a fluorenyl group as a starting material, add 2 eq. Of its ear equivalent under the environment (# see: Example 9 described later). R is even in compounds of formula (VII). However, in this case, the R group can also be cleaved according to the method shown in step A of step (e) of changing the above method (see Example 10 described later). The above steps produce compound β of formula (VIII) in good yield. If necessary, by subjecting the reaction liquid to conventional purification adjustments such as distillation, extraction, washing, solvent evaporation, and column or thin layer chromatography, The compound of formula (VIII) can be isolated and purified. Furthermore, when stirred with the above organic and inorganic acids in a suitable solvent, the compound (VIII) can be added with a suitable acid. Β m fb) in this step "in, from the above step" (a) The obtained formula < VIII) Compound-2 1-(Please read the precautions on the back before filling in this page) Binding and binding paper size applicable to China National Standard (CNS) A4 # L grid (210X297 mm) 4 60446 __ 1. I B7_ V. Description of the invention IfA) ^ 3 '2 shovel and 2-substituted-1,3-oxazoline derivative of the above formula (V), instead, to prepare the compound of formula (I) according to the present invention . This step is performed in the same way as the method (i) or (ii) in the above method variation A. Using either (i) or (ii), if necessary, the reaction liquid can be subjected to conventional purification adjustments such as steaming, extraction, washing, solvent evaporation, and column or thin layer chromatography, which can then be isolated and purified. The compound of formula (I). When mixed with the above organic and inorganic acids in a suitable solvent, the compound of formula (I) obtained by changing A to C from the above method may be isolated in the form of an acid addition salt. In the acid addition salt thus obtained (especially the hydrochloride salt), a crystalline form having excellent storage stability as shown in the following examples can be easily obtained, which is very suitable as an intermediate for long-term storage. As detailed in Example 13 below, when the compound of formula (I) provided by the present invention is used according to the following scheme (D), a compound of formula (IX) with good yield can be obtained. Excellent antibacterial activity and can be administered orally when it is esterified. I Loading f ^ (Please read the notes on the back before filling this page) Printed by the Central Consumers Bureau of the Ministry of Economic Affairs, Printed by the Consumer Cooperatives-2-This paper size applies to the Chinese National Standard (CNS) A4 (210X297 mm) 460446 A7 B7 V. Description of the invention (w) Stream stalk (D)
HCIHCI
(諳先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局貝工消費合作社印製(谙 Please read the notes on the back before filling out this page) Printed by the Shellfish Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs
(IX) 於下文中,藉由實施例、製備實施和實驗實施例更詳 細地說明本發明。然而,本發明並不限於下列説明中' -2 3- 本紙張尺度適用中國國家標準(CNS ) A4規格(2!0X297公釐) 460446 A7 B7 五、發明説明( 附帶地,説明中之符號具有下列意義: Ac :乙醒基 PO :對-硝苄基 奮掄例1 Μ HBr (1) (2) 在溶解於110毫升乙醚中之94毫升溴溶液中,將80克 稀丙胺(1)於15 °C或以下之溫度逐滴加入,及在室溫« 拌1天。反應結束之後,藉由遇濾取出已沈積的結晶, 及以55毫升乙醚洗滌,然後進行真空乾燥,因此,得到 302.6克(産率:99.6¾)之2-溴甲基氰雜環丙烷氫溴酸 鹽(2)。 1 H-NMR (CD3 OD) δ: 3.35 (dd, 1H, J=9.89Hz, 14.19Hz), 3.71 (dd, 1H, J=3.30Hz, 14.19Hz), 3.86 (dd, 1H, J=8.58Hz, 10.89Hz), 4.01 (dd, 1H, J=4.62Hz; 10.89Hz), 4.4-4.6 (m, 1H) 謇掄例2 '(IX) Hereinafter, the present invention will be described in more detail by way of Examples, Preparation Practices and Experimental Examples. However, the present invention is not limited to the following descriptions:-2 3-This paper size applies to the Chinese National Standard (CNS) A4 specification (2! 0X297 mm) 460446 A7 B7 V. Description of the invention (incidentally, the symbols in the description have The following meanings: Ac: EthyloxyPO: p-nitrobenzylphenone Example 1 M HBr (1) (2) In 94 ml of bromine solution dissolved in 110 ml of ether, 80 g of dilute propylamine (1) was added to 15 ° C or below is added dropwise and stirred at room temperature for 1 day. After the reaction is completed, the deposited crystals are removed by filtration, washed with 55 ml of ether, and then dried in vacuum, so 302.6 is obtained G (yield: 99.6¾) of 2-bromomethylcyanelanine hydrobromide (2). 1 H-NMR (CD3 OD) δ: 3.35 (dd, 1H, J = 9.89Hz, 14.19Hz) , 3.71 (dd, 1H, J = 3.30Hz, 14.19Hz), 3.86 (dd, 1H, J = 8.58Hz, 10.89Hz), 4.01 (dd, 1H, J = 4.62Hz; 10.89Hz), 4.4-4.6 ( m, 1H) Example 2 '
H (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製H (Please read the notes on the back before filling this page) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs
HCI (1) (3) 將900毫升包含9.M*升硫醯氮和催化量之溶解於其 中的碘的二氮甲烷乾燥溶液於40"C進行回流,及將100 -24- 本紙張尺度適用中國國家標準(CNS ) A4規格(2丨0X297公釐) 86.460446 修-工 A7 B7 五、發明説明(4 ) 毫升之包含7. 6毫升溶解於其中之稀丙胺(1)的二氱甲烷 乾燥溶液加至此溶掖中,及在該加入結束之後,該溶液 於相同溫度下携拌2小時。該反應结束之後,將反應溶 液放置至逹室溫,然後藉由過濾獲得之一殘留物以二氣 甲烷和正己烷清洗,及接箸進行真空乾燥,因此,得到 8.37克(産率:65.8¾)之卜氮甲基氮雜環丙烷筮氮酸鹽 (2 ) 0 H-NMR (DjO) δ: 3.26 (dd, 1H, J=9.57Hz, 13.85Hz), 3.53 (dd, 1H, J=3.30Hz, 13.85Hz), 3.78 (dd 1H, 6.60Hz, 12.21Hz), 3.88 (dd, 1H, J=4.95Hz, 12.21Hz), 4.38-4.47 (m, 1H) 啻掄例3 H N. • HCiHCI (1) (3) 900 ml of a diazomethane dry solution containing 9.M * liter of thiosulfur nitrogen and a catalytic amount of iodine dissolved therein was refluxed at 40 " C, and 100 -24- this paper size Applicable to China National Standard (CNS) A4 specification (2 丨 0X297 mm) 86.460446 Repair-work A7 B7 V. Description of the invention (4) ml of dimethylamine containing 7.6 ml of dilute propylamine (1) dissolved in it The solution was added to this solution, and after the addition was completed, the solution was stirred at the same temperature for 2 hours. After the reaction was completed, the reaction solution was left to room temperature, and then one of the residues obtained by filtration was washed with methane and n-hexane, and then vacuum-dried. Therefore, 8.37 g (yield: 65.8¾) was obtained. ) Azidomethylazepine (2) 0 H-NMR (DjO) δ: 3.26 (dd, 1H, J = 9.57Hz, 13.85Hz), 3.53 (dd, 1H, J = 3.30 Hz, 13.85Hz), 3.78 (dd 1H, 6.60Hz, 12.21Hz), 3.88 (dd, 1H, J = 4.95Hz, 12.21Hz), 4.38-4.47 (m, 1H) Example 3 H N. • HCi
m - hci --------- 裝-- (請先閲讀背面之注意事項再填寫本頁) 經濟部中央榡车局工消费合作社印製 (3) ⑷ (5) 在氮氣壓下於-78 °C下佾拌25毫升包含1.28克在上述 實施例2所得之2 -氣甲基氮雜璟丙烷氛酸鹽(3)的四氳 呋喃懸浮液,及將21毫莫耳正丁基鋰經5分鐘期間逐滴 加至該溶液中。在該加入結束之後,該溶液於相同溫度 下搜拌1小時,及同時放置反蘸溶液以使其逹室溫,該 溶液再攪拌1Q分鐘。將2毫升50%氫氣化鉀水溶液加至 該反應液體中.及攪拌1D分鐘。之後,於常壓下蒸皤該 反應液體,因此獲得具約51 eC沸點之卜氮雜雙環〔1.1.0 -25 本紙張尺度適用中國國家標準(CNS ) A4規格(2!0><297公釐) 农年月》86.3.25 A7 B7 五、發明説明(>4 ) 丁烷(4)。所得蒸籣液以氫氣化押和硪酸鉀乾燥,然後 冷卻至- 4Q°C,及將5毫升包含1.1 3毫升甲酸之四氫呋 喃溶液逐滴加至該蒸籣液中β將反窸溶液放置至達室溫 .然後再攛拌18小時,接著在減壓下濃縮該溶爾,及於 (TC將16片1包含60毫荚耳濃鹽酸之甲酵溶液加至該溶液 中,及随後將該溶液檯拌20小時》该反蘸结束之後,於 真空下蒸發溶劑,因此,得到570毫克(産率:52.0%) 於無色針狀结晶形式之3-羥基氘雜琛丁烷氫氡酸翔(5)β 1 H-NMR CD? Ο) δ: 4.0^4.3 (m, 2H) , 4.1-4.3 (m, 2H). 4.6-4.8 (m, 1H) 窗油ί俐4m-hci --------- Loading-(Please read the notes on the back before filling in this page) Printed by the Central Automobile Industry Bureau Industrial and Consumer Cooperatives of the Ministry of Economic Affairs (3) ⑷ (5) Under nitrogen pressure 25 ml of a tetrahydrofuran suspension containing 1.28 g of the 2-gas methylazepine propane cyanate (3) obtained in the above Example 2 was stirred at -78 ° C, and 21 millimoles of n-butyl Lithium was added dropwise to the solution over a period of 5 minutes. After the end of the addition, the solution was searched and stirred at the same temperature for 1 hour, and at the same time, a reverse dipping solution was placed to allow it to reach room temperature, and the solution was stirred for another 1 minute. 2 ml of a 50% potassium hydroxide aqueous solution was added to the reaction liquid, and stirred for 1D minutes. After that, the reaction liquid was distilled under normal pressure, so a diazabicyclic ring having a boiling point of about 51 eC was obtained. [1.1.0 -25 This paper is in accordance with China National Standard (CNS) A4 specification (2! 0 > < 297 Mm) Agricultural Year and Month "86.3.25 A7 B7 V. Description of the invention (> 4) Butane (4). The obtained distilling solution was dried with hydrogenated hydrogen and potassium acetate, and then cooled to -4Q ° C, and 5 ml of a tetrahydrofuran solution containing 1.13 ml of formic acid was added dropwise to the distilling solution. Allow to reach room temperature. Then stir for 18 hours, then concentrate the solvent under reduced pressure, and add 16 pieces of 1 formic acid solution containing 60 millipod concentrated hydrochloric acid to the solution, and then add The solution was stirred for 20 hours. After the back dipping was completed, the solvent was evaporated under vacuum. Therefore, 570 mg (yield: 52.0%) of 3-hydroxydeuterated butane hydrofluoric acid was obtained in the form of colorless needle crystals. (5) β 1 H-NMR CD? 〇) δ: 4.0 ^ 4.3 (m, 2H), 4.1-4.3 (m, 2H). 4.6-4.8 (m, 1H) window oil 4
ΝΗ · HGiΝΗ · HGi
N-^ N~i S—1 <請先聞讀背面之注意事項再填寫本頁) 經濟部中夬標準局貝工消費合作社印製 (i)於室溫下将5.G9克碩酸氳押加至73Jg升之包含7.95 克於實施例3所得之3-羥基氮雜琛丁烷氳氯酸鹽(5)甲 酵酐溶液中,然後逐滴加入9.67克2-(甲硫基)-1,3 -味 唑啉,然後將所得溶液進行加熱及回流20小時β將反應 溶液放置至逹室溫後再加入3_63克碩酸氫鉀,及該液篇 於相同溫度攪拌1小時·該反應结束之後,藉由過濾除 去沈澱物,及於真空下蒸發溶劑,然後將1()0毫升四g 呋喃加至該殘皆物中及將所得混合物於室溫携拌1小時 。以過濾除去不溶物質,及於真空下蒸發溶劑,然後將 -26- 本紙9L尺度逋用中國國家橾车(CNS ) A4*MM 210X297公釐) 460阪 ΪΕN- ^ N ~ i S—1 < Please read the notes on the back before filling out this page) Printed by Shelley Consumer Cooperative, China Standards Bureau, Ministry of Economic Affairs (i) 5.G9 grams of sour acid at room temperature Add 73 Jg liter of the solution containing 7.95 g of 3-hydroxyazepine butane chlorochloride (5) formic anhydride obtained in Example 3, and then dropwise add 9.67 g of 2- (methylthio). -1,3-oxazoline, and then the resulting solution was heated and refluxed for 20 hours. Β The reaction solution was left to 逹 room temperature, and then 3_63 g of potassium hydrogen sulfonate was added, and the solution was stirred at the same temperature for 1 hour. After the reaction was completed, the precipitate was removed by filtration, and the solvent was evaporated under vacuum, and then 1 g (4 ml) of four g of furan was added to the residue and the resulting mixture was stirred at room temperature for 1 hour. Remove insoluble materials by filtration, and evaporate the solvent under vacuum. Then use -26-paper 9L scale with China National Car (CNS) A4 * MM 210X297 mm) 460
丨丨献V Α7 Β7 經濟部中央標準局貝工消費合作社印裝 五、發明説明()丨 丨 V V Α7 Β7 Printed by the Shellfish Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs
該殘留物進行矽凝謬管柱層析(溶析液:氣仿-甲醇)及 因此,得到8.23克(産率:71,5!ϊ)於無色結晶形式之3-羥基-1-(1,3-噻唑啉-2-基)氮雜環丁烷(6)。 ®.p.108〜110C IR (K B r ) : v cnr 1 1 6 1 5, 1 3 7 2, 1 1 28, 1 010The residue was subjected to silica gel column chromatography (eluent: gas-form-methanol) and, as a result, 8.23 g (yield: 71,5! Ϊ) of 3-hydroxy-1- (1) was obtained in the form of colorless crystals. , 3-thiazolin-2-yl) azetidine (6). ®.p.108 ~ 110C IR (K B r): v cnr 1 1 6 1 5, 1 3 7 2, 1 1 28, 1 010
SI3X 1 H-NMR (CDClj ) δ: 3.356 (t, 2H, J=7.26Hz), 3·70~4.00 (fn, 4H), 4.211 (t, 2H, J = 8.21Hz), 4.622~ 4.705 (m, 1H), 4.971 (s, 1H) (ii)於氪氣流下將1.5毫升之包含219毫克<3-羥基氮雜 環丁烷(5)之乙腈酐溶液冷卻至0-C,及將0.31毫升三乙 胺加至此溶液中及随後加入〇·3毫升之包含25 0毫克氣乙 基異硫腈酸鹽溶解於其中之乙腈酐溶液,及所得溶液於 相同溫度下攪拌30分鐘及將反應溶液放置至達室溫後, 該溶液再攪拌2小時。接著將二氣甲烷加至該反鼴液饅 中,及以硝酸鉀飽和水溶液洗滌該所得溶液,之後以硫 酸鎂乾燥該二氣甲烷層,然後於滅壓下濃縮,因此,得 到300毫克(産率:95%)於無色針狀結晶形式之3 -羥基 -1-(1,3-!f唑啉-2-基)氮雜琛丁烷(6)。 此産物之HMR光譜完全與上迷(i)所得産物之光譜相同。SI3X 1 H-NMR (CDClj) δ: 3.356 (t, 2H, J = 7.26Hz), 3.70 ~ 4.00 (fn, 4H), 4.211 (t, 2H, J = 8.21Hz), 4.622 ~ 4.705 (m , 1H), 4.971 (s, 1H) (ii) Under a krypton current, cool 1.5 ml of an acetonitrile solution containing 219 mg of < 3-hydroxyazetidine (5) to 0-C, and cool 0.31 Ml of triethylamine was added to this solution and then 0.3 ml of an acetonitrile solution containing 25.0 mg of gas ethyl isothionitrate dissolved therein was added, and the resulting solution was stirred at the same temperature for 30 minutes and the reaction was After the solution was allowed to reach room temperature, the solution was stirred for another 2 hours. Next, digas methane was added to the reaction solution, and the resulting solution was washed with a saturated aqueous solution of potassium nitrate, and then the digas methane layer was dried with magnesium sulfate, and then concentrated under reduced pressure. Therefore, 300 mg (product Yield: 95%) of 3-hydroxy-1- (1,3-! Fazolin-2-yl) azepine butane (6) in the form of colorless needle-like crystals. The HMR spectrum of this product is exactly the same as that of the product obtained in (i) above.
(i)將6毫克Ν,Ν-二甲胺基吡啶加至2毫升之包含790 毫克於上述實施例4所得之3 -羥基3-喀唑啉-2- -2 7 - 本紙張尺度適用中國國家標準(CNS ) Α4规格(210X297公釐) ---------•裝------訂------線 (請先W讀背面之注意事項再填寫本頁) 460446 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明 (>fc ) 1 1 基 )氮雜璟丁烷(6) 之 四 氳呋 喃 酐 懸 浮 液 中同時 該 懸浮 液 1 1 以 冰 冷 卻 * 随 後加 入 5 5 7毫克三乙胺及E 75毫克 甲 mm 基 1 1 氣 同 時 該 懸 浮 液以 冰 冷 卻, 及 所 得 屁 合 物於相 同 溫度 攪 請 1 1 拌 40分 鐘 〇 該 反應 結 束 之後 t 於 真 空 下 蒸發溶 劑 ,然 後 先 鬩 1 1 將 乙 酸 乙 酯 加 至該 殘 留 物中 » 及 以 磺 酸 氫納之 飽 和水 溶 •Λ 背 1 1 液 洗 m 所 得 m 合物 〇 然 後, 所 得 水 層 進 一-步以 乙 酸乙 酯 之 注 I 意 | 萃 取 〇 以 硫 酸 鎂乾 燥 所 得有 機 層 之 後 9 於真空 下 蒸發 溶 事 項 ·! I 再 1 劑 9 及 將 該 殘 留物 進 行 矽凝 膠 管 柱 層 析 (溶析液 :氣仿- 填 甲 醇 )及因此, 得到9 95 毫克 (産率 84 . 396 )於 無 色結 晶 寫 本 頁 裝 1 形 式 之 3- 甲 磺 酵氣 基 -1 -(1 , 3- If 唑 啉 -2 -基)氮 雜 環丁 院β I 1 I 1 H-NMR (CDC1. .270 MHz, ppm) δ: 3. 07 (sp 3Η), 1 1 | 3 . 39 (t, 2H r J=7.6Hz), 4.03 (t· 2H, J = 7.6Hz), 4 14—4·19 1 訂 1 1 (m, 2H), 4, 37-4.31 (m, 2H), 5 .28-5.33 (m, 1Η) 接 箸 t 在 室 溫將 228毫克硫乙酸鉀加至1毫升包含1 18 1 1 毫 克 從 上 述 反 應所 得 之 3 -甲 磺 m 氣 基 -1 -(1,3- in 唑啉 ™ 2 — 1 1 基 )氮雜環丙烷之二甲基甲醯胺酐的溶液中,及該混合 红 \ 物 於 80 °c 攪 拌 4小 時 〇 該反 應 結 束 之 後 ,於真 空 下蒸 發 1 溶 劑 9 然 後 加 入乙 酸 乙 酯之 後 以 m 酸 氫之飽 和 水溶 液 1 i 洗 滌 該 溶 液 > 然後 » 所 得水 層 以 乙 酸 乙 酯進行 回 萃取 0 [ I 以 硫 酸 m 乾 燥 所得 有 機 層之 後 Ϊ 及 將 該 殘留物 進 行矽 凝 1 ! m 管 柱 層 析 (溶析液: 氣仿) 及 因 此 ) 得 到8 8毫 克 (産率: ! I 8 1 ,2 % )於淡黃色相 Ϊ狀物質班 J式之3 -乙醛硫基- 1 - (1,3 -it 1 1 唑 啉 -2 -基)氡 雜環 丁 院 ⑴。 1 I -2 8- 1 ! 1 1 本紙張尺度適用中國國家標準(CNS 規格(210X 297公釐) B7 涕充 86L3.25 五、發明説明(>?) 1 R (淨):V ίί 1 1 6 9 5, 1 6 1 6, 1 3 6 1, 1 1 3 2 〇 (請先閲讀背面之注意事項再填寫本頁) 1 H-NMR (CDCIj > δ: 2.333 (s, 3Η) , 3.352 (t. 2Η, J=7.26Hz), 3.885 (dd, 2H, J=8.24, 5.28Hz)p 4.012 (t,2H,J=7.26Hz),4.250〜4.374(m,1H),4.426(t.2H, J=8.25Hz) (ii)将119毫克3-經基-1-U,3 -喀唑啉-2-基)氮雜琿 丁烷(6)和2契耳當量之乙硫酸加至包含2莫耳當量之 三苯基除和2莫耳當量之β氮二甲酸鹽之四氫呋喃溶液 中,及所枵溶液於相同溫度下攪拌1小時及室溫再攛拌 1小時。於真空下蒸發反應液體中之溶劑,所得殘留物 進行矽凝膠管柱層析(溶析液:氯仿-乙酵)因此,得到 107毫克(産率:65% >淡黃色油狀物之3-乙醯硫基-1- (1 , 3-瞎唑W -2-基)氮雜琛丁烷(?)β 此産物之NHR光譜完全與上述(i)所得産物之光譜相同, 窗旆期I fi(i) Add 6 mg of Ν, Ν-dimethylaminopyridine to 2 ml containing 790 mg of 3-hydroxy3-carazoline-2- -2 7 obtained in Example 4 above-This paper is for China National Standard (CNS) Α4 Specification (210X297 mm) --------- • Installation ------ Order ------ Wire (Please read the precautions on the back before filling this page ) 460446 A7 B7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. 5. Description of the invention (> fc) 1 1) Tetrahydrofuran anhydride suspension of azabutane (6) and the suspension 1 1 to Ice cooling * Subsequently, 5 5 7 mg of triethylamine and E 75 mg of methylmmyl 1 1 gas were added while the suspension was cooled with ice, and the resulting fart mixture was stirred at the same temperature for 1 1 and stirred for 40 minutes. The reaction was completed After that, the solvent was evaporated under vacuum, and then ethyl acetate was added to the residue first »and dissolved in saturated water of sodium hydrogen sulfonate. Λ back 1 1 was washed with m to obtain m compound. Then, the water was obtained. Step by step-note with ethyl acetate Extraction 〇 After drying the organic layer obtained with magnesium sulfate 9 Evaporation under vacuum ·! I re-agent 9 and the residue was subjected to silica gel column chromatography (eluent: aeroform-filled with methanol) and Thus, 9 95 mg (yield 84.396) was obtained in colorless crystals. This page was packed in the form of 3-methylsulfanyl-1- (1,3-If oxazoline-2-yl) azetidine. Β I 1 I 1 H-NMR (CDC1. .270 MHz, ppm) δ: 3. 07 (sp 3Η), 1 1 | 3. 39 (t, 2H r J = 7.6Hz), 4.03 (t · 2H , J = 7.6Hz), 4 14-4 · 19 1 order 1 1 (m, 2H), 4, 37-4.31 (m, 2H), 5.28-5.33 (m, 1Η) then 箸 t at room temperature Add 228 mg of potassium thioacetate to 1 ml containing 1 18 1 1 mg of 3-methanesulfonium m-airyl-1-(1,3-in oxazoline ™ 2-1 1yl) azepine The solution of dimethylformamide anhydride and the mixed red product were stirred at 80 ° C for 4 hours. After the reaction was completed, the solvent 9 was evaporated under vacuum and then ethyl acetate was added. Then the solution was washed with a saturated aqueous solution of hydrogen acid 1 i> then »the resulting aqueous layer was back-extracted with ethyl acetate 0 [I after the organic layer obtained was dried with sulfuric acid m and the residue was subjected to silica gel 1 m Column chromatography (eluent: aeroform) and therefore) 8 8 mg (yield:! I 8 1, 2%) was obtained in the form of a pale yellow substance in the form of 3-J-acetaldehydethiol-1 -(1,3 -it 1 1 oxazoline-2 -yl) 氡 heterocycline. 1 I -2 8- 1! 1 1 This paper size applies to Chinese national standards (CNS specifications (210X 297 mm) B7 sputum 86L3.25 V. Description of the invention (>?) 1 R (Net): V ίί 1 1 6 9 5, 1 6 1 6, 1 3 6 1, 1 1 3 2 〇 (Please read the notes on the back before filling out this page) 1 H-NMR (CDCIj > δ: 2.333 (s, 3Η), 3.352 (t. 2Η, J = 7.26Hz), 3.885 (dd, 2H, J = 8.24, 5.28Hz) p 4.012 (t, 2H, J = 7.26Hz), 4.250 ~ 4.374 (m, 1H), 4.426 (t .2H, J = 8.25Hz) (ii) Add 119 mg of 3-caproyl-1-U, 3-carazolin-2-yl) azapine butane (6) and 2 kel equivalents of ethyl sulfate To a tetrahydrofuran solution containing 2 mole equivalents of triphenyl addition and 2 mole equivalents of β-azadicarboxylate, and the solution was stirred at the same temperature for 1 hour and at room temperature for another 1 hour. Under vacuum The solvent in the reaction liquid was evaporated under reduced pressure, and the obtained residue was subjected to silica gel column chromatography (eluent: chloroform-acetase). Thus, 107 mg (yield: 65%) of 3- Acetylthio-1- (1,3-brazolyl W-2-yl) azazenbutane (?) Β The NHR spectrum of this product is complete Same as (i) the spectrum of the product obtained above, a window of I fi pennant
N~~ N—ηN ~~ N-η
HCI (8) 經濟部中央標準局貞工消費合作社印製 將12. 9 8克在上逑實施例5所得之3-乙酵硫基-1-(1,3 瞎唑啉-2-基)氮雜環丁烷(7)溶解於58毫升之異丙醇中, S該經冰冷卻之所得溶液加入37.3毫升之溶解於甲醇中 之氫氧化鉀溶液(1.69N),及將該所得溶液攪拌1D分鐘β 然後於相同溫度,將66毫升氫氣酸溶液(2Ν)加至上述溶 液中以使其泮熄,及所得溶液在室溫攪拌15分鐘之後, -29- 本纸張尺度適.用中圉國家標準(CNS ) ( 210 X 297公釐) A7 B7 4 6兑4 4 6 8S.3. 2 5 五、發明説明(Μ ) 薛由過濾除去不溶物質。將濃缩濾液所得殘留物溶解於 33毫升異丙醇中,及以過濾除去不溶物質。濃缩液。將 58.5毫升正丁醇加至所得殘留物中以使該殘留物可被濃 缩,及因此,得到3 -靆基-1-(1,3-¾唑啉-2-基)氮雜環 丁烷鹽酸鹽(8)之白色固體β 將22.8毫升之乙腈加至該固體中,且得混合物於室溫 攪拌15分鐘以使混合物溶解,然後經30分鐘期間逐滴加 入113.4毫升之丙酮。然後,經15分鐘期間再逐滴加入 113.4毫升之丙酮,所得溶液攪拌30分鐘,同時以冰冷 卻。沈積之固體進行過濾,然後以150毫升之丙_洗滌 ,接著於減壓下乾燥一天,及因此,得到10.41克(純度 :9 7 · 5 % ,産率:8 0 . 3 % )於無色針狀結晶之3 -魏基-1 -(1,3-噻唑啉-2-基)氮雜環丁烷鹽酸鹽U)。HCI (8) Printed by the Zhengong Consumer Cooperative of the Central Bureau of Standards, Ministry of Economic Affairs, 12.98 grams of 3-ethionylthio-1- (1,3 oxazoline-2-yl) obtained in Example 5 of Shangying Azetane (7) was dissolved in 58 ml of isopropanol. The ice-cooled solution was added to 37.3 ml of a potassium hydroxide solution (1.69 N) dissolved in methanol, and the obtained solution was stirred. 1D minutes β Then, at the same temperature, 66 ml of a hydrogen acid solution (2N) was added to the above solution to extinguish it, and the resulting solution was stirred at room temperature for 15 minutes.圉 National Standard (CNS) (210 X 297 mm) A7 B7 4 6 to 4 4 6 8S.3. 2 5 V. Description of the Invention (M) Xue You removed insoluble matter by filtration. The residue obtained by concentrating the filtrate was dissolved in 33 ml of isopropanol, and insoluble matters were removed by filtration. Concentrate. 58.5 ml of n-butanol was added to the obtained residue so that the residue could be concentrated, and thus, 3-fluorenyl-1- (1,3-¾azolin-2-yl) azetidine was obtained. White solid β of alkane hydrochloride (8) 22.8 ml of acetonitrile was added to the solid, and the mixture was stirred at room temperature for 15 minutes to dissolve the mixture, and then 113.4 ml of acetone was added dropwise over a period of 30 minutes. Then, 113.4 ml of acetone was added dropwise over a period of 15 minutes, and the resulting solution was stirred for 30 minutes while cooling with ice. The deposited solid was filtered, and then washed with 150 ml of propylene, followed by drying under reduced pressure for one day, and thus, 10.41 g (purity: 97.5%, yield: 80.3%) was obtained in a colorless needle. 3-Wieryl-1-(1,3-thiazolin-2-yl) azetidine hydrochloride U).
® · ρ . 1 2 4 〜1 2 6 C I R ( Κ Β Γ ) : V cr 1 1 6 3 8 , 1 4 5 5 , 1 1 3 2 〇 iaax 1H-NMR (C0C13) δ: 2.57 (d, 1H, J=8.2Hz), 3.59 (t, 2H, J=7.4Hz), 4.02-4.18 (m, 4H), 4.63 (t, 2H, J= 7.4Hz), 5.19-5.26 (m, 1H), 12.19 (s, 1H) 此産物藉由棰化顯微鏡觀察確認為結晶。除此之外, X -射線繞圖示中,顯示於下列各晶格空間(d )(單位:A) 之待歡峰 7.32, 5.96, 5.04, 5.00, 4.90, 4.44, 4.23, 4.08, 3.79, 3.71, 3.66, 3.29, 3.14, 3.10, 2.98, 2.91, 2.82, 2.55, 2.50 附帶地,將上逑結晶濾液和丙酮洗液濃縮,及該所得 殘留物溶解於毫升正丁酵及然後再濃縮,接箸於減壓 -3 0 - 本紙張尺度適用中國國家標隼(CNS > A4規格(210X297公釐) * 奸参 I 訂 知 (請先閱讀背面之注意事叹再填寫本頁) 經濟部中央標隼局員工消費合作社印製 經濟部中央標準局員工消費合作社印製 4 6 0 4 4 6 A7 B7五、發明説明(Μ ) 下乾燥一天。將1.7毫升乙腈加至1.7克所得橙色固體中 ,所得混合物於室溫闱拌15分鐘以使其溶解,將17毫升 丙酮經1 5分鐘期間逐滴加至所得溶液中,所得溶液攢拌 30分鐘,同時以冰冷卻,及因此,得到1.2克(純度: 89.3¾ ;産率:8.5% }於無色針狀結晶形式之3-镟基-1-(1,3-瞎唑啉-2-基)氮雜環丁烷鹽酸鹽(8)。® · ρ. 1 2 4 to 1 2 6 CIR (Κ Β Γ): V cr 1 1 6 3 8, 1 4 5 5, 1 1 3 2 〇iaax 1H-NMR (C0C13) δ: 2.57 (d, 1H , J = 8.2Hz), 3.59 (t, 2H, J = 7.4Hz), 4.02-4.18 (m, 4H), 4.63 (t, 2H, J = 7.4Hz), 5.19-5.26 (m, 1H), 12.19 (s, 1H) This product was confirmed to be crystalline by observation with a tritiated microscope. In addition, the X-ray winding diagram is shown in the following lattice spaces (d) (unit: A): 7.32, 5.96, 5.04, 5.00, 4.90, 4.44, 4.23, 4.08, 3.79, 3.71, 3.66, 3.29, 3.14, 3.10, 2.98, 2.91, 2.82, 2.55, 2.50 Incidentally, the supernatant crystal filtrate and the acetone washing solution were concentrated, and the obtained residue was dissolved in ml of n-butase and then concentrated.箸 Decompression-3 0-This paper size applies to Chinese National Standards (CNS > A4 size (210X297 mm) * ginseng I order (please read the notice on the back before filling this page) Central Ministry of Economic Affairs Printed by the Employees 'Cooperative of the Bureau of Standards, printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs, printed 4 6 0 4 4 6 A7 B7 V. Description of the invention (M) and dried for one day. Add 1.7 milliliters of acetonitrile to 1.7 grams of the obtained orange solid. The resulting mixture was stirred at room temperature for 15 minutes to dissolve it, 17 ml of acetone was added dropwise to the resulting solution over a period of 15 minutes, and the resulting solution was stirred for 30 minutes while cooling with ice, and thus, 1.2 g ( Purity: 89.3¾; Yield: 8.5%} 3- 镟 in colorless needle-like crystal form 1- (1,3-blind 2-yl) azetidine hydrochloride (8).
(2) ⑷ (―N -^ —S (9) 於-78 °C下將5.94毫升(1.63M)之正丁基鋰逐滴加至12 毫升包含1.00克在上述實施例1所得之2-溴甲基氮雜環 丙烷溴酸鹽(2)的四氫呋喃懸浮液中,及所得溶液攪拌 1小時。於常壓下將該反應溶液蒸餾於水浴(30°C)中取 出各蒸發部份组,及因此,得到溶解於四氫呋喃之1-氟 雜雙環〔1.1.0〕丁烷(4)。 另一方面,將181毫克(55%)氫化納加至5毫升包含 550毫克(4.61毫莫耳)之經以冰冷卻的1,3-喀唑啉-2-碕 酮的乾燥四氫呋喃之溶液中,及該Μ合物攪拌1小時。 於-78 °C下將上述溶解於四氫呋喃之卜氮雜雙環〔1.1.0〕 -3 1 -(2) ⑷ (―N-^ —S (9) At -78 ° C, 5.94 ml (1.63M) of n-butyllithium was added dropwise to 12 ml containing 1.00 g of 2- obtained in Example 1 above. In a tetrahydrofuran suspension of bromomethylazepine bromate (2), and the resulting solution was stirred for 1 hour. The reaction solution was distilled in a water bath (30 ° C) under normal pressure, and each evaporation part group was taken out. And thus, 1-fluorobicyclo [1.1.0] butane (4) dissolved in tetrahydrofuran was obtained. On the other hand, 181 mg (55%) of sodium hydride was added to 5 ml containing 550 mg (4.61 mmol) The ice-cooled solution of 1,3-carazolin-2-fluorenone in dry tetrahydrofuran was stirred with the M compound for 1 hour. The above-mentioned azabicyclic ring dissolved in tetrahydrofuran was dissolved at -78 ° C. 〔1.1.0〕 -3 1-
.1 ^------.π------線 (讀先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) d604r4^.1 ^ ------. Π ------ line (read the precautions on the back before filling in this page) The paper size applies to China National Standard (CNS) Α4 size (210X297 mm) d604r4 ^
A7 B7 五、發明説明(> ) 丁烷逐滴加至所得溶液中,及所得溶液於室溫攪拌2 0小 時,然後反應液體進行高效液體層析,及因此.得到白 色粉末2-(氮雜環丁 -3-基硫)-1,3-嗛唑琳(9)。 b . p . 181~ 184¾ IRCKBr) : v 1 1628, 1510, 1309, 1237 max 1044 H-NMR (CDj 〇D) 6: 3.32 (t, 2H, J=8Hz) , 3.46 (dd, 2H, J=6Hz, 10Hz)( 3.90 (dd, 2H, J=8Hz, 10Hz), 4.06 (t, 2H, J=8Hz), 4.3-4.5 (m, 1H) 弯掄俐《A7 B7 5. Description of the invention (>) Butane was added dropwise to the resulting solution, and the resulting solution was stirred at room temperature for 20 hours, and then the reaction liquid was subjected to high-performance liquid chromatography, and thus, white powder 2- (nitrogen Heteridine-3-ylthio) -1,3-oxazoline (9). b. p. 181 ~ 184¾ IRCKBr): v 1 1628, 1510, 1309, 1237 max 1044 H-NMR (CDj 〇D) 6: 3.32 (t, 2H, J = 8Hz), 3.46 (dd, 2H, J = 6Hz, 10Hz) (3.90 (dd, 2H, J = 8Hz, 10Hz), 4.06 (t, 2H, J = 8Hz), 4.3-4.5 (m, 1H)
r—Nr—N
(9) N— S—1 (10) 經濟部中央標準局貝工消費合作社印製 將0.329毫升甲磺酸加至包含從上述實施例7所得之 2-(氮雜琛丙-3-基)-1,3-喀唑啉(9)之四氫咲喃酐溶液 中,然後於減壓下濃縮該溶劑,将甲醇加至所得溶液中 ,及該所得溶液進行加熱及回流3小時β該反_结束之 後,蒸餾掉溶劑,及該殘留物藉由高效液體層析分離及 純化,及因此,得到1δ6毫克(産率:23.2%)本發明之 淡黃色油狀物3 -頸基- l- (lt3 -嗦唑咐-2 -基)氮雜環丁烷 (10)。 Ιίί (淨):i/C01:1 1616, 1359, 1 007 〇 DldX 以氫氣酸處理之上述化合物(10)之NMR光譜與上述實 施例6之化合物(8 )的光譜完全相同。 啻掄例Q fj « HBrZA^r —(9) N—S—1 (10) Printed by the Shellfish Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs, adding 0.329 ml of methanesulfonic acid to 2- (azaazapropan-3-yl) obtained from Example 7 above -1,3-carazoline (9) in a solution of tetrahydrofuran anhydride, and then the solvent was concentrated under reduced pressure, methanol was added to the obtained solution, and the obtained solution was heated and refluxed for 3 hours. After the end, the solvent was distilled off, and the residue was separated and purified by high-performance liquid chromatography, and thus, 1δ6 mg (yield: 23.2%) of the light yellow oily substance of the present invention 3-neck-l- (lt3 -oxazolyl-2-yl) azetidine (10). Ιίί (net): i / C01: 1 1616, 1359, 1 007 〇 The NMR spectrum of the above-mentioned compound (10) treated with hydrogen acid was the same as the spectrum of the above-mentioned compound (8) of Example 6. Example Q fj «HBrZA ^ r —
(4) --------政------tr------^ (請先閱讀背面之注意事項再填寫本頁) ⑵ 3 2- 本紙張尺度適用中國圉家標牟(CNS > A4洗格(210X297公釐)(4) -------- 政 ------ tr ------ ^ (Please read the precautions on the back before filling out this page) ⑵ 3 2- This paper size is applicable to Chinese households Standard Mou (CNS > A4 Washer (210X297 mm)
NAc 4 60446 經濟部中央標隼局員工消費合作社印黎 A7 _B7五、發明説明(〜) 藉由如上述實施例7相同之方法,使用2.00克在實施 例1所得之2-溴甲基氮雜環丙烷氫溴酸鹽(2)製備卜氣雜 雙環〔1.1.0〕丁烷(4)溶解於四氫呋喃中之溶液。接著 ,於-4(TC或更低之溫度將溶解於四氫呋喃中之化合物(4) 之溶液逐滴加至包含1_32毫升硫乙酸之乾燥四氫呋喃的 溶液中,及所得混合物於室粗下攪拌18小時β該反應结 束之後,蒸»掉溶繭,及該殘留物《内矽凝膠管柱層析 (溶析液:氛仿-丙銅)分離及純化,及因此,得到828毫 克(産率:51.8%)卜乙醯基-3-乙醯基硫氮雜琛丁烷(11>。 1 H-NMR (CDClj ) δ: 1.87 {s, 3H), 2.35 (s, 3H), 3.89 (dd. 1/2 x 2H, J=5Hz , 10Hz), 4.01 (dd, 1/2 x 2H, J=5Hz, 9Hz), 4.1-4.2 (m, 1H), 4.42 (t, 1/2 x 2H, J= tOHz), 4.61 (t, 1/2 x 2H, J=10Hz) >- hs-^Q \h · HCI (12) 將l.D毫升之2.6N之氫第酸加至104¾克於上述實施 例9得到之1-乙醒基-3-乙酵基硫氮雜環丙烷(11)中, 及所得溶液進行加熱及回流1小時。該反應结束之後, 加入水,及以乙酸乙酯洗滌該溶液,然後於真空中蒸發 水層。所得殘留物於真空中乾燥,及因此,得到71毫克 (産率:94.4% )3-蕺基-氪雜環丁烷(12)。 -3 3 -NAc 4 60446 Employees' Cooperatives of the Central Bureau of Standards, Ministry of Economic Affairs, Consumer Cooperatives, India, A7 _B7 V. Description of the Invention (~) By the same method as in Example 7 above, 2.00 g of 2-bromomethylazapine obtained in Example 1 was used. Cyclopropane hydrobromide (2) to prepare a solution of diazabicyclo [1.1.0] butane (4) dissolved in tetrahydrofuran. Next, a solution of the compound (4) dissolved in tetrahydrofuran was added dropwise to a solution containing 1-32 ml of thioacetic acid in a dry tetrahydrofuran at a temperature of -4 ° C or lower, and the resulting mixture was stirred for 18 hours in a crude chamber. β After the reaction was completed, the cocoon was distilled off, and the residue was separated and purified by "inner silica gel column chromatography (eluent: chloroform-propyl copper), and 828 mg (yield: 51.8%) diethylsulfanyl-3-ethylsulfanylazetidine butane (11 >. 1 H-NMR (CDClj) δ: 1.87 {s, 3H), 2.35 (s, 3H), 3.89 (dd. 1/2 x 2H, J = 5Hz, 10Hz), 4.01 (dd, 1/2 x 2H, J = 5Hz, 9Hz), 4.1-4.2 (m, 1H), 4.42 (t, 1/2 x 2H, J = tOHz), 4.61 (t, 1/2 x 2H, J = 10Hz) >-hs- ^ Q \ h HCI (12) Add 1 ml of 2.6N hydrogen dicarboxylic acid to 104¾ g in the above example In the obtained 1-ethoxy-3-ethynylthioazapropane (11), the obtained solution was heated and refluxed for 1 hour. After the reaction was completed, water was added, and the solution was washed with ethyl acetate. And then the water layer was evaporated in vacuo. The residue obtained was dried in vacuum and, as a result, 71 mmol was obtained G (yield: 94.4%) 3-fluorenyl-fluorenbutane (12). -3 3-
AcSAcS
(11) 本紙張U適用中國國家標準(CNS ) A4規格(210 x 297公釐) f請先閲讀背面之注意事項再填寫本頁) 丨裝· 、π 460446 A7 B7 五、發明説明(θ ) 1 H-NMR (D, Ο) δ: 4.0-4.3 (m. 3H), 4.5-4.7 (m, 2H) (3) N · HCI ^丨(11) This paper U applies the Chinese National Standard (CNS) A4 specification (210 x 297 mm) f Please read the notes on the back before filling in this page) 丨 Installation · π 460446 A7 B7 V. Description of the invention (θ) 1 H-NMR (D, Ο) δ: 4.0-4.3 (m. 3H), 4.5-4.7 (m, 2H) (3) N · HCI ^ 丨
+ HS+ HS
(12)(12)
HCI 使用1.2 8克在實施例2所得之2-氰甲基氰雜琛丙烷氫 氛酸BM3)製備包含1-氰雜雙琛〔1.1.0〕丁烷(4)之四 氬呋喃的溶液。該溶液以氳氣化鉀及碩酸鉀乾嫌之後, 於室缠逐滴加入〇·85毫升硫乙酸,及所得溶掖於相同粗 度下*拌1小時之後.於減壓下濃縮該反觴掖醴,然後 加入3.33毫升之3Ν氬氣酸,所得溶液進行加熱和Θ流1 小時β放置反應液翯以使其逹溫室,將3 0毫升水加至其 中,及以乙酸乙酯洗滌所得溶液。藉由分雄所得之水相 與從萃取有機層而得之水相放在一起,然後於真空中蒸 發該溶爾,及因此,得到91 3毫克(産率:72.7% )3-统 基-1-»雜琛丁烷氫氦酸鹽(12)。 化合物(12)之HMR光譜與上逑實施例10之化合物的光 譜完全相同》 I -^I^^ (請先閱讀背面之注意事項再填寫本頁) 經滴部中央標準局員工消費合作社印製HCI used 1. 28 g of 2-cyanomethylcyanazinepropane hydrocyanic acid BM3) obtained in Example 2 to prepare a solution containing 1-cyanobischen [1.1.0] butane (4) in argonfuran. After the solution was dried with osmium potassium and potassium sulphate, 0.85 ml of thioacetic acid was added dropwise to the chamber, and the resulting solvent was stirred at the same thickness * for 1 hour. The reaction was concentrated under reduced pressure. Then, 3.33 ml of 3N argon acid was added, and the resulting solution was heated and Θ flow for 1 hour. Β was placed in the reaction solution to make it a greenhouse, 30 ml of water was added thereto, and the obtained solution was washed with ethyl acetate. Solution. The aqueous phase obtained by separating males was put together with the aqueous phase obtained from the extraction of the organic layer, and then the solvent was evaporated in a vacuum, and thus, 91.3 mg (yield: 72.7%) of 3-methyl- 1- »heterobutane butane hydrohelium salt (12). The HMR spectrum of compound (12) is exactly the same as that of the compound of Example 10 above. I-^ I ^^ (Please read the precautions on the back before filling this page)
ΝΗ · HCIΝΗ · HCI
HCI 34 本纸張尺度適用中國國家標準(CNS ) Α4規格(210 X W7公釐) 此産物之NMR光辑舆上述實施例6之所得産物的光譜 完全相同。 4 6 0 4 4 ' A7 B7 五、發明説明(4 ) 將26.6克2-(甲碕基)-1,3-喀唑啉和5.2毫克三笨基麟 加至於溶解95%甲醇(包括1毫升之水)之22.7毫克於上 述實施例11得到之3-頚基-1-氮雜環丁烷氫氣酸鹽(12) 的溶液中,及該所得溶液進行加熱及回流6小時。該反 慝結束之後,於真空中蒸皤掉溶剤,及將所得殘留物溶 解於(K1H氳氛酸中,及所得混合物以乙酸乙酯洗滌β於 真空中蒸發掉所得水相中的溶劑,及所得殘留藉由高效 液醱層析分離及純化,及因此,得到29.1毫克(産率: 73.4% )3-頸基-1-(1 ,3-喀唑啉-2-基)氮雜環丁烷氳氣 酸鹽(8)。 ------------^------ΪΤ------威 (請先閣讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 於室溫下氮氣流中將0.07毫升三乙胺加至於溶解1.0 毫升之乾操四氫呋喃中之63.3毫克於上述實施例1Q得到 之3 -魏基-雜環丙烷氫氣酸鹽(12)的溶液中,及該所得 溶液攪拌30分鐘。將70. 3毫克溶解於乾燥四氫呋喃中之 2 -氯乙基異氰酸鹽加至此溶液中,及該所得溶液再攢拌 1小時。反應溶液冷卻至〇°C之後,逐滴加入0.04毫升 甲磺酸,及將該所得溶液攪拌30分鐘,然後在真空中蒸 -3 5 -HCI 34 This paper size is in accordance with Chinese National Standard (CNS) A4 specification (210 X W7 mm). The NMR spectrum of this product is exactly the same as that obtained in Example 6 above. 4 6 0 4 4 'A7 B7 V. Description of the invention (4) 26.6 g of 2- (methylamidino) -1,3-carazoline and 5.2 mg of tribenzylline were added to dissolve 95% methanol (including 1 ml) 22.7 mg of water) in a solution of the 3-fluorenyl-1-azetidine hydrochloride (12) obtained in Example 11 above, and the resulting solution was heated and refluxed for 6 hours. After the reaction was completed, the solvent was distilled off in vacuo, and the resulting residue was dissolved in K1H aquatic acid, and the resulting mixture was washed with ethyl acetate. The solvent in the resulting aqueous phase was evaporated in vacuo, and The obtained residue was separated and purified by high performance liquid hydration chromatography, and thus, 29.1 mg (yield: 73.4%) of 3-neckyl-1- (1,3-carazolin-2-yl) azetidine was obtained. Alkyl hydrochloride (8). ------------ ^ ------ ΪΤ ------ WEI (Please read the precautions on the back before filling this page) Printed by the Consumer Cooperative of the Central Bureau of Standards, Ministry of Economic Affairs, adding 0.07 ml of triethylamine to 1.0 ml of dry tetrahydrofuran dissolved in 1.0 ml of dry tetrahydrofuran in a nitrogen stream at room temperature. In a solution of propane hydrochloride (12), and the resulting solution was stirred for 30 minutes. 70.3 mg of 2-chloroethyl isocyanate dissolved in dry tetrahydrofuran was added to this solution, and the resulting solution was re-simmered Stir for 1 hour. After the reaction solution is cooled to 0 ° C, 0.04 ml of methanesulfonic acid is added dropwise, and the resulting solution is stirred for 30 minutes, then in a vacuum. -35--
(12) (13) 本紙張尺度適用中國國家標準(CNS ) A4規格(2IOX29?公釐) 4 6CUUL·^ 修 ίν ^ fi免 h 86. 3. 25 A7 B7 五、發明説明(知 及1;熱 將行 -進 劑液 溶溶 該得 發所 至 加 醇 甲 燥 乾 升 毫 殘 得 中 物 及 流 回 溶 該 發 0 中 空 真 在 後 然(12) (13) This paper size applies Chinese National Standard (CNS) A4 specification (2IOX29? Mm) 4 6CUUL · ^ 修 ίν ^ fi free h 86. 3. 25 A7 B7 V. Description of the invention (Knowledge and 1; The heat will dissolve the agent-into the liquid to dissolve the hair to the dry place with alcohol and dry the residue to obtain the neutrals and flow back to dissolve the hair.
薄 由 藉 m-2Λ琳 § 田(isBi 殘克噻 得毫3-所4 1’ 3 ( 05 t 劑到I 基 得基 ,頸 S3 ο 因之3 及質ί -物鹽 化狀酸 純油磺 及色甲 離黃烷 ,分淡丁 時析於環 小層W雜 1 層2°m ffl , P ·- IR (淨):1^^ 1 1 6 5 3, 1 56 0, 1 1 50, 1 05 0 1 H-NMR(CDCla )5ppui: 2.97(s, 3H), 3.63(t, 2H, J=7.3Hz)、3.94〜4.17(®,4H),4.38 .67(m, 1H)、4.99(iri, 1H)。Boyou borrowed m-2Λ 琳 § Tian (isBi residual thiodermide 3-so 4 1 '3 (05 t agent to I base, neck S3) so 3 and the quality of salt-like acid pure oil Sulfur and chroman are separated from flavane, and they are separated into small ring layer and W heterocycle 1 layer at 2 ° m ffl, P ·-IR (net): 1 ^^ 1 1 6 5 3, 1 56 0, 1 1 50 , 1 05 0 1 H-NMR (CDCla) 5ppui: 2.97 (s, 3H), 3.63 (t, 2H, J = 7.3Hz), 3.94 ~ 4.17 (®, 4H), 4.38.67 (m, 1H), 4.99 (iri, 1H).
HCI (8) —^1 1_ - -!1 _1 I - IJ^ I I I ----I . \~~Ψ -3 (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印裝HCI (8) — ^ 1 1_--! 1 _1 I-IJ ^ III ---- I. \ ~~ Ψ -3 (Please read the notes on the back before filling out this page) Staff Consumption of the Central Bureau of Standards, Ministry of Economic Affairs Cooperative print
(i)將700毫克於實施例6所得之3 -魏基-1-(1,3-喀唑 啉-2-基)氮雜環丁烷鹽酸盏(8)溶解於15毫升由水、乙 腈和氯仿之混合溶液中,將1668毫克對對-硝苄基(1R, -3 6 - 本紙張尺度適用中國國家標準(CNS ) A4規格(21 ο X 297公釐)(i) 700 mg of 3-Weiyi-1- (1,3-carazolin-2-yl) azetidine hydrochloride (8) obtained in Example 6 was dissolved in 15 ml of water and acetonitrile In a mixed solution of chloroform and chloroform, 1668 mg of p-nitrobenzyl (1R, -3 6-this paper size applies the Chinese National Standard (CNS) A4 specification (21 ο X 297 mm)
A 6 經滴部中央標準局貝工消費合作社印製 A7 B7 五、發明説明(衫) 5R,6S)-2-(二苯基磷氣基)-6- [ (R)-卜羥乙基〕_卜甲 基-碩配念-2-烯(em)-3-羧酸鹽(14)加至所得溶液中。於 m氣流中以冰冷卻之所得溶液中加入2,8毫?f =異丙s 乙胺,及所得混合物在相同溫度S拌2小時。將乙酸乙 酯加至該反應溶液中,及所得溶液以硪酸氫納飽和水溶 液和以氫化納飽和水溶液洗滌,及於宾空下蒸發溶剤, 及將該所得殘留物進行矽凝_管柱層析(溶析液:氣仿-丙振)及因此,産生1339¾克(産率:92¾)對-硝苄基( lR,5S,6S)-2-〔 唑啉-2-基)氮雜環丁烷-3-基A 6 Printed by Shelley Consumer Cooperative of the Central Standards Bureau of Didi A7 B7 V. Description of the invention (shirt) 5R, 6S) -2- (diphenylphosphine) -6- [(R) -Buhydroxyethyl ] -Methylmethyl-sulfonyl-2-ene (em) -3-carboxylate (14) was added to the obtained solution. To the resulting solution, which was cooled with ice in a stream of m, 2,8 milliliter was added. f = isopropyl s ethylamine, and the resulting mixture was stirred at the same temperature S for 2 hours. Ethyl acetate was added to the reaction solution, and the resulting solution was washed with a saturated aqueous solution of sodium hydrogen oxalate and a saturated aqueous solution of sodium hydride, and evaporated to dissolve in a bin, and the obtained residue was subjected to silica gel_column layer. (Eluent: aeroform-propionate) and, as a result, 1339¾ g (yield: 92¾) of p-nitrobenzyl (lR, 5S, 6S) -2- [oxazoline-2-yl) azacyclo Butane-3-yl
〕硫-6-〔(R) -卜羥乙基]-1-甲基-磺配念-2-烯-3-羧酸酯(15K 1 H-NMR (CDClj ) 6: 1.235 (d; 3H, J=7.26Hz), 1.349 (d, 3H, J=6.27Hz), 3.160 (quintet. 1H, J=7.26Hz). 3.265 (dd, 1H, 0=2.3, 6.26Hz), 3.367 (t. 2H, J=7.26HZ). 3.898〜4.038 (m, 4H), 4.071〜4.147 (m, 1H), 4.212〜4,278 (m, 2H> , 4.372 (2H, J = 7.92Hr), 5.255 and 5.517 (d(AB), 2H, J=13.85Hz), 7.665 (d, 2H, J=8.58Hz), 8.226 (d, 2H, J=8.58Hz) (ii)1339毫克從上述反應(i)所得之化合物(其像溶解 於20毫升四氫呋喃中)之溶液中,加人60毫升0.38K磷酸 鹽缓衝溶液(PH6.G)和11.2克鋅粉,及將該混合物猛烈 攪拌2小時。矽藻土(Celite®)過濾該反應溶液因此除 去不溶物質,然後滹液以乙酸乙酯洗滌之後調整至PH5.5 。然後,所得溶液於減壓下濃縮,及此濃縮溶液進行管 柱層析Diaion HP-40® (由三菱化學公司(Mitsubishi -3 7 - 本紙張尺度適用中國國家標準(CNS ) A4规格U丨OX297公釐} ^-- (請先閱讀背面之注項再填寫本I) •π] Sulfur-6-[(R) -hydroxylethyl] -1-methyl-sulfonan-2-ene-3-carboxylic acid ester (15K 1 H-NMR (CDClj) 6: 1.235 (d; 3H , J = 7.26Hz), 1.349 (d, 3H, J = 6.27Hz), 3.160 (quintet. 1H, J = 7.26Hz). 3.265 (dd, 1H, 0 = 2.3, 6.26Hz), 3.367 (t. 2H , J = 7.26HZ). 3.898 ~ 4.038 (m, 4H), 4.071 ~ 4.147 (m, 1H), 4.212 ~ 4,278 (m, 2H >, 4.372 (2H, J = 7.92Hr), 5.255 and 5.517 (d ( AB), 2H, J = 13.85Hz), 7.665 (d, 2H, J = 8.58Hz), 8.226 (d, 2H, J = 8.58Hz) (ii) 1339 mg of the compound obtained from the above reaction (i) (which Like a solution dissolved in 20 ml of tetrahydrofuran), add 60 ml of 0.38K phosphate buffer solution (PH6.G) and 11.2 g of zinc powder, and stir the mixture vigorously for 2 hours. Celite® The reaction solution was filtered to remove insoluble matters, and then the mash was adjusted to pH 5.5 after washing with ethyl acetate. Then, the resulting solution was concentrated under reduced pressure, and the concentrated solution was subjected to column chromatography Diaion HP-40® (from Mitsubishi Chemical Corporation (Mitsubishi -3 7-This paper size applies to Chinese National Standard (CNS) A4 specification U 丨 OX297 mm} ^-(Please read the back first Fill in the above notes and refill this I) • π
A7 B7五、發明説明()6 ) Chemical Corporation)裂造)(溶析液:異丙醇之5%水 溶液,異丙醇)分離及純化,及因此,産生861毫克(産 率:87%)所要之(1!?,53,65)-2-〔1-(1,3-__啉-2-基) 氮雜環丁烷-3-基]硫-6-〔(R)-卜羥乙基]-卜甲基- 碩配念-2-烯-3-羧酸鹽(16)。 1 H-NMR (D2 0) δ: 1.093 (d. 3H , J = 6.93Hz), 1.207 (d, 3H, J=6.27Hz), 3.05- 3.20 (m, 1H) . 3.357 (dd, 1H, J=2.3, 5.94Hz), 3.558 (t, 2H, J=7.26Hz), 3.920 (t. 2H, J=7.26Hz)· 4.00~ 4.20 (m, 5H), 4.20~ 4.30 (m, 1H), 4.60- 4.70 (m. 1H) IR (KBr): 1740, 1640, 1590 cm"1 實施例1 5 (請先閲讀背面之注意事項再填寫本頁)A7 B7 V. Description of the invention (6) Chemical Corporation) Cracking) (Eluent: 5% aqueous solution of isopropanol, isopropanol) Isolation and purification, and therefore, 861 mg (yield: 87%) The desired (1!?, 53,65) -2- [1- (1,3 -__ line-2-yl) azetidin-3-yl] thio-6-[(R) -bu Hydroxyethyl] -p-methyl-sulfonyl-2-ene-3-carboxylate (16). 1 H-NMR (D2 0) δ: 1.093 (d. 3H, J = 6.93Hz), 1.207 (d, 3H, J = 6.27Hz), 3.05- 3.20 (m, 1H). 3.357 (dd, 1H, J = 2.3, 5.94Hz), 3.558 (t, 2H, J = 7.26Hz), 3.920 (t. 2H, J = 7.26Hz) 4.00 ~ 4.20 (m, 5H), 4.20 ~ 4.30 (m, 1H), 4.60 -4.70 (m. 1H) IR (KBr): 1740, 1640, 1590 cm " 1 Example 1 5 (Please read the precautions on the back before filling this page)
N— S—J (8) HC!N— S—J (8) HC!
ch3 cooh 經濟部中央標準局員工消費合作社印裝 將實施例6中所得之化合物钞2 . 1克加至40毫升二氣 甲烷和2 0毫升5 0 % K 2 C 0 3水溶液之混合液中並激烈攪 拌。分離二氮甲烷層以MgSh乾燥後過濾。將6 00毫 克醑酸加至此濾液中並攪拌。所得溶液在減壓下濃縮 ,獲得2 . 3 4克淡黃色油狀物之化合物(1 7 )。 1 Η - N M R (C D C ] 3 ) δ p p u : 2 . 0 3 (s , 3 Η ) , 3 . 3 8 (t , 2 Η , J = 7 · 6 Η ζ ) 、3 ‘ 8 0 U , 1 Η ),3 . 9 4 ( m,2 Η ) 、4 . 0 3 (t,2 Η , J = 7 . 6 Η 2 )、4 . 4 8 (m,2 Η ) IR (淨):ϋ1 1652, 1612, 1361, 1258, 1008〇 〇)αΧ ~ 3 8 _ 本紙張尺度適用中國國家標準(CNS ) Α4规格(210Χ297公釐) 460446 ^ βΐ f]械充视3. 25 A7 B7 五、發明説明㈠1 ) 實施例1 6ch3 cooh The Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs printed 2.1 grams of the compound banknote obtained in Example 6 into 40 ml of digas methane and 20 ml of a 50% K 2 C 0 3 aqueous solution and Stir vigorously. The diazomethane layer was separated, dried over MgSh, and filtered. To this filtrate was added 600 mg of osmic acid and stirred. The resulting solution was concentrated under reduced pressure to obtain 2.34 g of the compound (17) as a pale yellow oil. 1 Η-NMR (CDC] 3) δ ppu: 2.0 3 (s, 3 Η), 3. 3 8 (t, 2 Η, J = 7 · 6 Η ζ), 3 '8 0 U, 1 Η ), 3. 9 4 (m, 2 Η), 4.03 (t, 2 Η, J = 7.6 Η 2), 4. 4 8 (m, 2 Η) IR (net): ϋ1 1652, 1612, 1361, 1258, 1008〇〇) α × ~ 3 8 _ This paper size applies to Chinese National Standards (CNS) A4 specifications (210 × 297 mm) 460446 ^ βΐ f] Mechanical charge 3. 25 A7 B7 V. Description of the invention ㈠1 ) Example 16
HCHC
得 獲 0 物 合 化 克 11 2 理 0 處8) 式(1 方物 同合 相化 述狀 上油 與色 黃 淡 克 8 3 3 3 9 9 7 0 3 1X 9 3 ΛΙΤ Η 1 w (. 9 7 II H 2 m /IV 1 5 ro 7 (5 2 2 11 IX 8 , 一 2 7 8 0 3 * r*H 8 、3 ΤΛ Η 6 3 1 m2 (5 5 6 \—/ \ly \1/ Η Η Η 2 2 2 ra Γ\ 基 魏 I 3 的 得 所 6 例 施 實 述 上 之 式 形 晶 1结 ••例色 }施無 淨實於 ί驗將 I實 呦月 唑個 噻一 3態 1,狀 基 結 (£度 鹽純 酸锪 鹽合 烷化 丁此 環認 雜確 氮-丨果 濕 除 中 室 於 置 變 改 有 没 都 點 (請先閱讀背面之注意事項再填寫本頁) 性 定 安 存 儲 之 好 良2 具例 其施 此貢 因驗 ,實 於 量 損 法 方 列 下 由 藉Obtained 0 gram of compound 11 2 0 0 8) Formula (1 cubes in the same phase and described the oil and color yellow light gram 8 3 3 3 9 9 7 0 3 1X 9 3 ΛΙΤ Η 1 w (. 9 7 II H 2 m / IV 1 5 ro 7 (5 2 2 11 IX 8, 2 7 8 0 3 * r * H 8, 3 ΤΛ Η 6 3 1 m2 (5 5 6 \ — / \ ly \ 1 / Η Η Η 2 2 2 ra Γ \ Gewei I 3's gains 6 cases of the formula described in the above description 1 · • Example color} Shi Wujing's test of I will be the month of thiazolium, a thiazide, a 3-state 1, Base knot (pure salt, pure acid, phosphonium salt, alkylated butyl ring, and heterocyclic nitrogen-丨 fruit wet removal in the middle of the room to change or not (please read the precautions on the back before filling this page) The goodness of Ding'an Storage 2 is an example of its implementation, which is based on the method of loss measurement.
物 合 化 的 備 製 物 間 中 為 作 \1/ I—_ /IV 物 合 化 之 明 發 本 用 吏捐 巾U 4 6 1 1 /|\ 例 施 實 菌 性 法 方 驗 試 XT/ 1In the preparation room of the material synthesis, it is used as \ 1 / I —_ / IV for the chemical composition of the material and donated towels. U 4 6 1 1 / | \ Example of bactericidal method test XT / 1
ο法 eln釋 ch稀 e基 es養 aη培 ap旨 3 RH (J瓊 會用 協使 療法 治方 學準 化標 本之 By 據et 根cl ο S 卷e rty 1* 2 1 第ue r M py之 ra物 he生 ot微 e驗 c試οMethod eln release ch thin e base es raise a n training ap purpose 3 RH (J Qiong will use synergy therapy to treat the standard specimens of By, according to et root cl ο S volume e rty 1 * 2 1 th ue r M py ra物 生生 ot e e test c test
V 含3 包於 -基 上養 際培 實體 。液 3脂 1)瓊 00 V—ί 9 Η 1 Μ /IV /(V 經濟部中央標準局員工消費合作社印策 使包 稀 後於 液 Ξ 然W 容 )?〇 孵 SG升丨 (B毫 膠\約 水胞各 鹽細液 食e釋 衝10稀 緩約此 以為Γ) 基度te 養濃an 培之P1 得物ΓΟ 所生1C 及微(Π. ,驗管 夜試滴 過使量 養以撤 培釋用 w 之小 物最 合之 化長 驗生 試物 ,生 此徹 因驗 〇試 上到 基察 養觀 培有 脂沒 瓊後 Η Μ時 之小 I 8 物1 合育 化孵 駿V 試37 含於 度。 濃株 制準 抑標 小為 最偽 為物 傲生 度徼 濃之 此 於 用 使 有 所 地 帶 附 中 ΤΑ 表 下 於 示 顯 果 結 之 驗 果實 結 )¾上 本紙張尺度適用中國國家標準(CNS > A4規格(210X25·7公釐> 46044- A7 B7五、發明説明(从) 經濟部中央標準局員工消費合作社印製 丟 1 : μ τr ( ». g/n. η 試驗榭生物 金色鍵霉菌FDA2 0 9 P JC- 1 金色鍵霉® Teraji臟a 金色鍵塞菌MS353 醸膿鍵球睹Cook 枯草桿菌ATCC 6633 藤黃撖球齠A T C C 9 3 4 1 大腸桿菌 NIHJ JC-2 大腸桿® K- 1 2 C800 陰溝勝桿菌963 産氣腸桿菌 ATCC 1 3 0 4 8 肺炎克氏桿菌 PCI-602 鼠傷寒桿菌 UD971 傷寒桿菌 301 副傷寒桿菌 1 0 1 5 蒸苗勒氏桿菌 80fl6 腸炎桿菌(314 鋈桿菌 I AH 1 184 磨氏變形菌 IF0 3848 奇異變形菌 I F 0 3 8 4 9 普通變形菌 0P19 普通變形_ HX- 19 雷氏變形菌 IF0 3850 試驗化合.,物(16) 0.013 £ 0.006 < 0.006 < 0.006 0.025 0.2 0.013 0.1 0.05 0.1 0.013 0.025 g 0.006 0.05 0.025 0.39 0.05 0.39 0.39 0.39 從上逑結果可知:本發明提供之式(I)化合物為有效 之具有優異抗菌活性之化合物的中間物。 本紙張尺度適用中國國家標隼(CNS) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) 裝 丁 -°V contains 3 enveloping culture entities. Liquid 3 fat 1) Joan 00 V—ί 9 Η 1 Μ / IV / (V The policy of the staff consumer cooperative of the Central Standards Bureau of the Ministry of Economic Affairs makes the package thinner than the liquid.) W) Incubate SG liters ((B gelatin) \ About water cells, each salt, fine liquid, food, e, release, 10, dilute, and think about Γ), the basic degree te, enriched with an anesthesia, P1, and Γ, 1C and micro (Π., Test tube night test drip to make the amount of nutrition Release the best test of the test w using the w test, and then test the test result. The test is performed on the small I 8 test 1 when the test is completed and the test is completed. Jun V Test 37 Contained in degrees. The quasi-suppressed standard made by the thick plant is the most fake. It is the most pseudo-physical degree. This is used to make the zone attached. The table below shows the fruit results. Paper size applies to Chinese national standards (CNS > A4 specifications (210X25 · 7 mm > 46044- A7 B7) V. Description of the invention (from) Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 1: μ τr (». G / n. η Test organisms Aureobasidium aureus FDA2 0 9 P JC-1 Aureus aureus® Teraji viscera aureus aureus MS353 The pus key ball see Cook Bacillus subtilis A TCC 6633 Garcinia coccineus ATCC 9 3 4 1 E. coli NIHJ JC-2 E.coli® K- 1 2 C800 Enterobacter cloacae 963 Enterobacter aerogenes ATCC 1 3 0 4 8 Klebsiella pneumonia PCI-602 Typhoid typhoid UD971 Typhoid fever Bacillus 301 Paratyphoid 1 0 1 5 M. steamer 80fl6 Enterobacter (314 Pseudomonas I AH 1 184 Proteus Moor IF0 3848 Proteus mirabilis IF 0 3 8 4 9 Common Proteus 0P19 Common Deformation_ HX- 19 Proteus raisii IF0 3850 Test combination., (16) 0.013 £ 0.006 < 0.006 < 0.006 0.025 0.2 0.013 0.1 0.05 0.1 0.013 0.025 g 0.006 0.05 0.025 0.39 0.05 0.39 0.39 0.39 According to the above results, it can be known that: provided by the present invention: The compound of formula (I) is an effective intermediate with a compound with excellent antibacterial activity. The size of this paper is applicable to China National Standard (CNS) A4 (210X297 mm) (Please read the precautions on the back before filling this page) Ding- °
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP33142394 | 1994-12-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW460446B true TW460446B (en) | 2001-10-21 |
Family
ID=18243508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW84113172A TW460446B (en) | 1994-12-12 | 1995-12-11 | Thiol compounds |
Country Status (2)
Country | Link |
---|---|
TW (1) | TW460446B (en) |
ZA (1) | ZA9510546B (en) |
-
1995
- 1995-12-11 TW TW84113172A patent/TW460446B/en not_active IP Right Cessation
- 1995-12-12 ZA ZA9510546A patent/ZA9510546B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA9510546B (en) | 1996-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1281720C (en) | Carbapenem compounds and production thereof | |
ES2803516T3 (en) | A crystalline form of linezolid | |
TW420681B (en) | Carbapenem-3-carboxylic acid ester derivatives | |
DK144763B (en) | ANALOGY PROCEDURE FOR PREPARING CEPHALOSPORINE DERIVATIVES | |
EA023955B1 (en) | Aminoalkyl-substituted n-thienyl benzamide derivative | |
JPS58198490A (en) | Chemical compound | |
JP2021161114A (en) | Methylation of Mcl-1 compound | |
AU2023202036B2 (en) | Azabicyclo and diazepine derivatives for treating ocular disorders | |
CN100522920C (en) | Method for preparing 4-bromine 2,6-difluoro benzoic acid | |
JP2000515532A (en) | Azabicyclic carbamoyloxymutilin derivatives for antibacterial use | |
Hwang et al. | Diastereoselective 1, 2-addition of lithiated N-(trialkylsilyl) methylphenylsulfoximines to aldehydes: preparation of 1, 4, 3-oxathiazin-2 (6H)-one 4-oxides as novel cyclic sulfoximines | |
JPH06503078A (en) | 4,5-dihydroxy- and 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid dicarbonates and urethanes with therapeutic activity | |
TW460446B (en) | Thiol compounds | |
US20110021624A1 (en) | Alpha-Amino-N-Substituted Amides, Pharmaceutical Composition Containing Them and Uses Thereof | |
CN103038234B (en) | There is for clostridium the compound of anti-microbial activity | |
FR2542316A1 (en) | PROCESS FOR THE PREPARATION OF CARBAPENEM DERIVATIVES, NOVEL INTERMEDIATES FOR SYNTHESIS AND PROCESS FOR THE PREPARATION OF SUCH INTERMEDIATES | |
PT717042E (en) | PROCESS FOR PREPARING DERIVATIVES OF 1- (4,5-DIHYDRO-2-THIAZOLYL) -3-AZETIDINE-TIOL | |
JPH02292237A (en) | Alpha-fluoroshikimic acid derivative, preparation thereof, pharmaceutical composition containing same for treating bacteria and fungus infection, bactricide and herbicide contaning same and intermediate therefor | |
Hamdani et al. | Preparation, spectral characterization, crystal structure and antibacterial activity of two new supramolecular complexes [Ni (phen) 2Cl (H2O)] 2 (PF6) 2.2 caf. H2O (I),[Ni (phen) 2 (H2O) 2] 2 (PF6) 4. 3caf. 4H2O (II) constructed via hydrogen bond linking | |
Kim et al. | Synthesis and Antibacterial Activity of 1beta-Methyl-2-[5-(alpha, beta-disubstituted ethyl) pyrrolidin-3-ylthio] carbapenem Derivatives. Part II | |
TW201747B (en) | ||
JP2531489B2 (en) | 1-β-methyl-2-thiol carbapenem derivative and method for producing the same | |
SU1169541A3 (en) | Method of obtaining iodmethyl 6-(d-2-azido-2-phenyl acetamido)-penicillanoyloxymethyl carbonate | |
CA2264806A1 (en) | Novel .beta.-lactam compounds and process for preparing the same | |
US3322768A (en) | Aralkyl piperazines and salts thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GD4A | Issue of patent certificate for granted invention patent | ||
MK4A | Expiration of patent term of an invention patent |